CN112236499A - Compound and liquid-crystalline medium - Google Patents

Compound and liquid-crystalline medium Download PDF

Info

Publication number
CN112236499A
CN112236499A CN201980035960.2A CN201980035960A CN112236499A CN 112236499 A CN112236499 A CN 112236499A CN 201980035960 A CN201980035960 A CN 201980035960A CN 112236499 A CN112236499 A CN 112236499A
Authority
CN
China
Prior art keywords
compounds
group
atoms
formula
fluorinated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980035960.2A
Other languages
Chinese (zh)
Inventor
A·格特兹
S·玛格
R·弗尔特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CN112236499A publication Critical patent/CN112236499A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • C09K19/2014Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups containing additionally a linking group other than -COO- or -OCO-, e.g. -CH2-CH2-, -CH=CH-, -C=C-; containing at least one additional carbon atom in the chain containing -COO- or -OCO- groups, e.g. -(CH2)m-COO-(CH2)n-
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3444Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/123Ph-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/124Ph-Ph-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/301Cy-Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring
    • C09K2019/3425Six-membered ring with oxygen(s) in fused, bridged or spiro ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The invention relates to compounds of formula (I), and preferably liquid-crystalline media having a nematic phase and a negative dielectric anisotropy, comprising a) one or more compounds of formula (I)
Figure DDA0002802810560000011
And b) one or more compounds selected from the group consisting of compounds of the formulae (II) and (III)

Description

Compound and liquid-crystalline medium
The present invention relates to novel compounds, in particular for liquid-crystalline media, but also to the use of these liquid-crystalline media in liquid-crystal displays, and to these liquid-crystal displays, in particular liquid-crystal displays using the ECB (electrically controlled birefringence) effect with dielectrically negative liquid crystals in the homeotropic initial alignment. The liquid-crystalline media according to the invention are distinguished by particularly short response times in the displays according to the invention, at the same time by a high voltage holding ratio (VHR or also just HR for short).
The principle of electrically controlled birefringence, the ECB effect or the DAP (aligned phase distortion) effect was first described in 1971 (m.f. schieckel and k.fahrenschon, "Deformation of biological liquid crystals with vertical orientation in electrical fields", appl.phys.lett.19(1971), 3912). Followed by papers from j.f. kahn (appl.phys.lett.20(1972),1193) and g.labrunie and j.robert (j.appl.phys.44(1973), 4869).
The papers of J.Robert and F.Clerc (SID 80Digest techn. papers (1980),30), J.Duchene (Displays 7(1986),3) and H.Schad (SID 82Digest techn. papers (1982),244) have shown that the liquid crystal phase must have a high value of the ratio of the elastic constants, K3/K1High values of optical anisotropy Deltan and dielectric anisotropy values of Deltaepsilon ≦ -0.5 for high information display elements based on the ECB effect. Electro-optical display elements based on the ECB effect have a homeotropic edge alignment (VA technique, also referred to as vertical alignment, or VAN, vertical alignment nematic). Dielectrically negative liquid-crystalline media can also be used in displays using the so-called IPS (in-plane switching) effect.
Industrial application of this effect in electro-optical display elements requires LC phases which have to meet a wide variety of requirements. Of particular importance here are chemical resistance to moisture, air and physical influences such as radiation in the thermal, infrared, visible and ultraviolet regions and also direct and alternating electrical fields.
Furthermore, it is desirable that the industrially usable LC phase has a liquid crystalline mesophase in a suitable temperature range and a low viscosity.
None of the series of compounds having a liquid crystalline mesophase disclosed so far includes a single compound that satisfies all of these requirements. Thus, in general, mixtures of 2 to 25, preferably 3 to 18, compounds are prepared in order to obtain substances which can be used as LC phases.
Matrix liquid crystal displays (MLC displays) are known. Non-linear elements that can be used for independent switching of individual pixels are, for example, active elements (i.e., transistors). The term "active matrix" is then used, wherein in general Thin Film Transistors (TFTs) are used, which are usually arranged on a glass plate as substrate.
A distinction is made between two techniques: TFTs comprising compound semiconductors (e.g. CdSe) or TFTs based on polycrystalline and especially amorphous silicon. The latter technology is currently of greatest commercial importance worldwide.
The TFT matrix is disposed on the inside of one glass plate of the display, while the other glass plate carries a transparent counter electrode on its inside. The TFT is very small compared to the size of the pixel electrode and has almost no adverse effect on the image. The technique can also be extended to full colour displays where mosaic (mosaic) of red, green and blue filters are arranged in such a way that the filter elements are located with respect to each switchable pixel.
TFT displays most used so far are typically operated with crossed polarizers in transmission and are backlit. For TV applications, IPS cells or ECB (or VAN) cells are used, whereas monitors typically use IPS cells or TN (twisted nematic) cells, and notebook, laptop and mobile applications typically use TN cells.
The term MLC display here covers any matrix display with integrated non-linear elements, i.e. in addition to an active matrix also displays with passive elements, for example varistors or diodes (MIM ═ metal-insulator-metal).
MLC displays of this type are suitable in particular for TV applications, monitors and notebooks, or for displays with a high information density, for example in automobile construction or aircraft construction. In addition to problems with respect to the angle dependence of the contrast and the response time, MLC displays also suffer from problems due to an insufficiently high specific resistance of the liquid-crystal mixture [ TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, Sept.1984: A210-one 288Matrix LCD Controlled by Double Stauble Stadiode Rings, pp.141ff., Paris; STROMER, M., Proc. Eurodisplay 84, Sept.1984: Design of Thin Film Transistors for Matrix Addressing of Television Liquid Crystal Displays, pp.145ff., Paris ]. As the resistance decreases, the contrast of the MLC display deteriorates. The specific resistance of the liquid crystal mixture generally decreases over the life of an MLC display due to interaction with the inner surfaces of the display, and a high (initial) resistance is therefore very important for displays which must have an acceptable resistance value over long periods of operation.
In addition to IPS displays (e.g. Yeo, S.D., paper 15.3: "An LC Display for the TV Application", SID 2004International Symposium, Digest of Technical Papers, XXXV, volume II, pages 758 and 759) and the long-known TN displays, displays using the ECB effect, so-called VAN (vertically aligned nematic) displays, have been recognized as one of the three newer types of liquid crystal displays which are currently most important, in particular for television applications.
The most important designs that can be mentioned here are: MVA (multi-domain vertical alignment type, e.g., Yoshide, H.et al, paper 3.1: "MVA LCD for Notebook or Mobile PCs.", SID 2004International Symposium, Digest of Technical Papers, XXXV, volume I, pages 6 to 9, and Liu, C.T. et al, paper 15.1: "A46-inch TFT-LCD HDTV Technology …", SID 2004International Symposium, Digest of Technical Papers, XXXV, volume II, pages 750 to 753), PVA (patterned vertical alignment type), e.g.: kim, Sang Soo, article 15.4: "Super PVA Sets New State-of-the-Art for LCD-TV", SID 2004International Symposium, Digest of Technical Papers, XXXV, volume II, pages 760 to 763) and ASV (advanced Super View, e.g.: shigeta, Mitzuhiro and Fukuoka, Hirofumi, paper 15.2 "Development of High Quality LCDTV", SID 2004International Symposium, Digest of Technical Papers, XXXV, volume II, pages 754 to 757).
In general form, this technique is compared in, for example, Souk, Jun, SID Seminar 2004, Seminar M-6, "Recent Advances in LCD Technology", Seminar features Notes, M-6/1 to M-6/26, and Miller, Ian, SID Seminar 2004, Seminar M-7, "LCD-tension", Seminar features Notes, M-7/1 to M-7/32. Although the response time of modern ECB displays has been significantly improved by overdrive (over drive) addressing methods, for example: kim, Hyeon Kyeong et al, article 9.1, "A57-in. wide UXGA TFT-LCD for HDTV Application", SID 2004International Symposium, Digest of Technical Papers, XXXV, volume I, pages 106 to 109, but the realization of video compatibility response times, especially in greyscale switching, is still a problem that has not been solved to a satisfactory extent.
ECB displays, like ASV displays, use liquid-crystalline media with a negative dielectric anisotropy (Δ ∈), whereas TN and up to now all conventional IPS displays use liquid-crystalline media with a positive dielectric anisotropy.
In this type of liquid crystal display, liquid crystals are used as dielectrics, the optical properties of which change reversibly upon application of a voltage.
Since in displays in general, i.e. also in displays according to these mentioned effects, the operating voltage should be as low as possible, liquid-crystalline media are used which are usually composed mainly of liquid-crystalline compounds which all have the same sign of the dielectric anisotropy and have the highest possible value of the dielectric anisotropy. In general, at most a relatively small proportion of neutral compounds is used, and if possible no compounds having the opposite sign of the dielectric anisotropy to the medium are used. In the case of liquid-crystalline media with negative dielectric anisotropy for ECB displays, compounds with negative dielectric anisotropy are therefore predominantly used. The liquid-crystalline medium used generally consists predominantly and usually even essentially of liquid-crystalline compounds having a negative dielectric anisotropy.
In the media used according to the application, usually at most significant amounts of dielectrically neutral liquid-crystalline compounds are used and usually only very small amounts of dielectrically positive compounds or even no dielectrically positive compounds are used, since in general liquid-crystal displays are intended to have the lowest possible addressing voltage.
The known liquid-crystalline media are not sufficiently stable for many practical applications in liquid-crystal displays. In particular, their stability to irradiation with UV and even with conventional backlighting leads to impairment, in particular of the electrical properties. Thus, for example, the conductivity is significantly increased.
The use of so-called "hindered amine light stabilizers", abbreviated to HALS, has been proposed for the stabilization of liquid crystal mixtures.
For example, it is proposed in WO 2009/129911A 1 and WO 2012/076105A 1 to include small amounts
Figure BDA0002802810550000051
770 nematic liquid crystal mixtures having negative dielectric anisotropy and using as stabilizers compounds of the formula
Figure BDA0002802810550000052
However, the corresponding liquid-crystal mixtures do not have sufficient properties for some practical applications. In particular, they are not sufficiently stable for irradiation using typical CCFL (cold cathode fluorescent lamp) and especially typical modern LED (light emitting diode) backlights.
Similar liquid crystal mixtures are also known, for example, from EP 2182046 a1, WO 2008/009417 a1, WO 2009/021671 a1 and WO 2009/115186 a 1. However, the use of stabilizers is not indicated in these documents.
According to the disclosure of these documents, these liquid-crystal mixtures may optionally also comprise various stabilizers, for example phenols and sterically hindered amines (hindered amine light stabilizers, HALS for short). However, these liquid-crystal mixtures are characterized by a relatively high threshold voltage and at best by mediocre stability. In particular, their voltage holding ratio decreases after exposure. Furthermore, the discoloration of the yellowish color is generally increased.
The use of various stabilizers in liquid-crystalline media is described, for example, in JP (S)55-023169(A), JP (H)05-117324(A), WO 02/18515A 1 and JP (H)09-291282 (A).
In particular, EP 2993216A 1 proposes stable compounds of the formula
Figure BDA0002802810550000053
In addition to other various as secondary stabilizers and in addition to nitrogen heterocyclic substances, WO 2009/129911A 1 also suggests stabilized compounds of the formula
Figure BDA0002802810550000061
EP 2514800A 2 proposes the use of compounds of the formula for the stabilization of liquid-crystalline media
Figure BDA0002802810550000071
Wherein R is11Among other meanings, O.or OH may be used instead of H. However, the chemical stability of these compounds with respect to hydrolysis and in particular their solubility in liquid-crystalline media is in most cases inadequate for practical applications.
WO 2016/146245A 1 proposes compounds of the formula for stabilization purposes in liquid-crystalline media.
Figure BDA0002802810550000072
DE 2016005083A 1 also proposes the use of the above-mentioned compounds and compounds of the formula
Figure BDA0002802810550000081
However, the chemical stability, in particular with regard to hydrolysis, and especially the solubility in liquid-crystalline media, is in most cases inadequate for practical use.
The unpublished application DE 102016009485.0, on the other hand, proposes ether-linked compounds of the formula as stabilizers for liquid-crystal mixtures.
Figure BDA0002802810550000082
Figure BDA0002802810550000091
The prior art liquid-crystalline media with correspondingly low addressing voltages have relatively low resistance values or low VHR and often lead to undesirable flicker and/or insufficient transmission in the display. Furthermore, they are not sufficiently stable to thermal/UV exposure, which is necessary for low addressing voltages, at least if they have a correspondingly high polarity.
On the other hand, the addressing voltage of prior art displays with high VHR is often too high, especially for displays that are not directly or continuously connected to the power supply network, for example for displays for mobile applications.
Furthermore, the phase range of the liquid crystal mixture must be sufficiently wide for the intended application of the display. Therefore, the low temperature storage at-30 ℃ in the box and preferably in bulk (in bulk) should be 240 hours or more.
The response time of the liquid-crystalline medium in the display must be improved, i.e. reduced. This is especially important for displays used for television or multimedia applications. To improve response time, it has been repeated in the pastIt is proposed to optimize the rotational viscosity (gamma) of the liquid-crystalline medium1) I.e. to achieve a medium with the lowest possible rotational viscosity. However, the results achieved here are not sufficient for many applications and, therefore, make it desirable to find additional optimization methods.
Sufficient stability of the medium to extreme loads, especially to UV exposure and heat, is of particular importance. This is particularly difficult for simultaneously optimizing the rotational viscosity. This may be important especially in the case of applications in mobile devices, such as displays in mobile phones, since in particular in these devices it is preferred to use a relatively low addressing frequency.
The disadvantages of the MLC displays disclosed to date are due to their comparatively low contrast, the relatively high viewing-angle dependence and the difficulty of grey scale generation in these displays, as well as their inadequate VHRs and their inadequate lifetimes.
Therefore, there is still a great need for MLC displays having very high specific resistance, at the same time having a large operating temperature range, short response times and low threshold voltages, by means of which various gray levels can be generated, in particular having good and stable VHRs.
It is an object of the present invention to provide MLC displays not only for monitor and TV applications, but also for mobile telephones and navigation systems, which are based on the ECB, IPS or FFS (edge field effect) effect, as described in Lee, s.h., Lee, s.l.and Kim, h.y. "Electro-optical characteristics and switching principle of a novel liquid crystal controlled by way of field switching", appl.phys.letters, vol.73, No.20, pp.2881-2883(1998), do not have the disadvantages indicated above, or only to a lesser extent do so, and at the same time have very high specific resistance values. In particular, for mobile phones and navigation systems it must be ensured that they also operate at extremely high and low temperatures.
Surprisingly, it has been found that liquid-crystal displays, in particular FFS displays, which have a low threshold voltage and short response times and at the same time a sufficiently broad nematic phase, advantageously a relatively low birefringence (. DELTA.n), good stability to decomposition by heat and by UV exposure, good solubility and a stable and high VHR can be achieved when nematic liquid-crystal mixtures comprising at least one compound of the formula I and in each case at least one compound of the formula II, preferably of the sub-formula II-1, and/or at least one compound selected from the group consisting of the compounds of the formulae III-1 to III-4, preferably of the formula III-2 and/or B are used in these display elements.
This type of medium can be used for electro-optical displays with active matrix addressing, in particular based on the ECB effect, and for IPS displays and for FFS displays.
The present invention therefore relates to liquid-crystalline media based on mixtures of polar compounds, comprising at least one compound of the formula I and at least one compound comprising one or more compounds of the formula II and preferably additionally one or more compounds selected from the group consisting of the compounds of the formulae III-1 to III-4 and/or the compounds of the formula B.
The mixtures according to the invention exhibit a very broad nematic phase range with a clearing point of > 70 ℃, very favourable values for the capacitance threshold, relatively high values for the retention and at the same time good low-temperature stability at-20 ℃ and-30 ℃ and very low rotational viscosity. The mixtures according to the invention are further characterized by a very good ratio of clearing point to rotational viscosity and by a high negative dielectric anisotropy.
It has surprisingly been found that liquid-crystalline media with a suitably high Δ ∈, a suitable phase range and Δ n can be achieved which do not have the disadvantages of the prior art materials or at least do so to a significantly reduced extent.
It has now surprisingly been found that the compounds of the formula I lead to a marked, in many cases sufficient, stabilization of the liquid-crystalline mixtures against UV exposure and heat even when used alone without additional heat stabilizers. This is the case in particular in most cases where the parameter p in the compounds of the formula I used represents 2 and n × p represents 4 or 6. In one embodiment of the invention, the formula wherein p represents 2 and n represents 3 or 4The compounds I are therefore particularly preferred, and the use of the precise compounds in the liquid-crystal mixtures according to the invention is also particularly preferred. Preference is likewise given to the radical-Z therein11-S11-Z12-represents an omega-dioxyalkylene group, i.e. -O-S11-O-of the formula I.
However, sufficient stabilization of the liquid-crystal mixtures with respect to UV exposure and with respect to heat can also be achieved, in particular in the case that, in addition to one or more compounds of the formula I, one or more further compounds, preferably phenolic stabilizers, are present in the liquid-crystal mixture. These other compounds are suitable as heat stabilizers.
The present invention therefore relates to compounds of the formula I and to liquid-crystalline media having a nematic phase and a negative dielectric anisotropy, comprising
a) One or more compounds of the formula I, preferably in a concentration of from 1ppm to 2500ppm, preferably to 2000ppm, preferably to 1500ppm, particularly preferably to 1000ppm, preferably in the range from 1ppm to 500ppm, particularly preferably in the range from 1ppm to 250ppm,
Figure BDA0002802810550000121
wherein
R11Each occurrence independently of the others represents H, F, a linear or branched alkyl chain having 1 to 20C atoms, one of which is-CH2-a group or, if present, a plurality of-CHs2The radical-may be replaced by-O-or-C (═ O) -but no two adjacent-CH groups2The radical being replaced by-O-, and one or, if present, more than one-CH2The radicals-CH-OR-C.ident.C-may be replaced by-CH-OR-C.ident.C-and one OR more H atoms may be replaced by F, OR13,N(R13)(R14) Or R15Instead of this, the user can,
R11preferably represents H or alkyl, particularly preferably n-alkyl and very particularly preferably n-butyl,
R12each occurrence independently of the other represents a straight chain having 1 to 20C atoms orBranched alkyl chain of which one is-CH2A group or a plurality of-CH2The radical-may be replaced by-O-or-C (═ O) -but no two adjacent-CH groups2The radical being replaced by-O-, a hydrocarbon radical comprising cycloalkyl or alkylcycloalkyl units, and in which one-CH2A group or a plurality of-CH2The radicals-may be replaced by-O-or-C (═ O) -without two adjacent-CH groups2The radical being replaced by-O-, and one OR more H atoms being able to be replaced by F, OR13,N(R13)(R14) Or R15Instead of, OR in addition to, aromatic OR heteroaromatic hydrocarbon radicals in which one OR more H atoms may be replaced by F, OR13,N(R13)(R14) Or R15Instead of this, the user can,
R12preferably represents H, unbranched alkyl or branched alkyl, particularly preferably H or unbranched alkyl,
R13each occurrence independently of the others represents a straight-chain or branched alkyl or acyl radical having 1 to 10C atoms, preferably an n-alkyl radical, or an aromatic hydrocarbon radical having 6 to 12C atoms or a carboxylic acid radical,
R14each occurrence independently of the others represents a straight-chain or branched alkyl or acyl radical having 1 to 10C atoms, preferably an n-alkyl radical, or an aromatic hydrocarbon radical having 6 to 12C atoms or a carboxylic acid radical,
R15each occurrence independently of the other represents a linear or branched alkyl group having 1 to 10C atoms, one of which is-CH2A group or a plurality of-CH2The radicals-may be replaced by-O-or-C (═ O) -without two adjacent-CH groups2The radical-is replaced by-O-,
S11and S12Each occurrence independently of the other denotes an alkylene radical having 1 to 20C atoms, which is branched or preferably straight-chain, - (CH) having preferably 1 to 20C atoms, preferably 1 to 10C atoms, particularly preferably 1 to 8C atoms2-)nOne of them is-CH2-a group or, if present, a plurality of-CHs2The radicals-may be replaced by-O-or-C (═ O) -without two adjacent-CH groups2The radicals being replaced by-O-, and one or moreIf present, a plurality of-CHs2The radicals-CH-OR-C.ident.C-may be replaced by-CH-OR-C.ident.C-and one OR more H atoms may be replaced by F, OR13,N(R13)(R14) Or R15Instead of, or in addition to, a single bond,
X11the expression C is shown in the specification,
Y11to Y14Independently of one another, each represents methyl or ethyl, particularly preferably both represent methyl or ethyl and very particularly preferably methyl,
Z11to Z14Independently of one another, each occurrence represents-O-, -C-O-O-, -C-O-, -O- (C-O) -O-, -N-R13)-,-N-R13- (C ═ O) -or if S11Is a single bond, but Z represents a single bond11And Z12Both do not represent-O-simultaneously, and, however, if S is12Is a single bond, Z13And Z14Both are not simultaneously-O-, and, however, if-X11[-R11]o-is a single bond, Z12And Z13The two are not simultaneously-O-,
Z11preferably represents-O-,
Z13preferably represents a single bond, and preferably represents,
p represents a number of 1 or 2,
o represents (3-p),
n p represents an integer from 3 to 10, preferably to 8,
in the case where p is 1,
n represents 3,4,5, 6 or 8, particularly preferably 4, 6 or 8, very particularly preferably 4 or 6, and,
m represents (10-n), and,
in the case where p is 2,
n represents an integer from 2 to 4, preferably 2 or 3, particularly preferably 3, and
m represents (4-n), and
Figure BDA0002802810550000141
denotes an organic group having (m + n) binding sites, preferably 4 binding sites, preferably 1Alkanediyl, alkanetriyl or alkanetetrayl units of up to 30C atoms, in which, apart from m radicals R present in the molecule12Furthermore, but independently thereof, one other H atom may be replaced by R12Instead of or in addition to one or more other H atoms, may be replaced by R12Instead, preference is given to having a mono-or bivalent alkanetetrayl unit on each terminal C atom, in which one-CH2A group or a plurality of-CH2The radicals-may be replaced by-O-or- (C ═ O) -in such a way that the two-O-atoms are not bonded directly to one another, or substituted or unsubstituted aromatic or heteroaromatic hydrocarbon radicals having a valency of up to 10, where the radicals R are present in the molecule in addition to m radicals R12Furthermore, but independently thereof, one other H atom may be replaced by R12Instead of or in addition to one or more other H atoms, may be replaced by R12Instead of this, the user can,
and-X in case p ═ 111[-R11]oAlternatively, it may also represent a single bond,
b) one or more compounds selected from the group consisting of compounds of formulae II and III, preferably being dielectrically positive, preferably having a dielectric anisotropy of each 3 or more:
Figure BDA0002802810550000142
wherein
R2Represents H, a non-fluorinated or fluorinated alkyl group or a non-fluorinated or fluorinated alkoxy group having 1 to 17C atoms, or a non-fluorinated or fluorinated alkenyl group having 2 to 15C atoms, a non-fluorinated or fluorinated alkenyloxy group or a non-fluorinated or fluorinated alkoxyalkyl group, wherein one or more CH are2The radicals may be
Figure BDA0002802810550000151
Instead, an alkyl group, an alkoxy group, a fluorinated alkyl group or a fluorinated alkoxy group having 1 to 7 carbon atoms, an alkenyl group, an alkenyloxy group, an alkoxyalkyl group or a fluorinated alkenyl group having 2 to 7 carbon atoms is preferred, and an alkyl group or an alkenyl group is preferred,
Figure BDA0002802810550000152
represent independently of each other at each occurrence
Figure BDA0002802810550000153
Wherein R isLRepresent, identically or differently on each occurrence, H or an alkyl radical having 1 to 6C atoms, or
Figure BDA0002802810550000154
Figure BDA0002802810550000161
Figure BDA0002802810550000162
Preferably
Figure BDA0002802810550000163
More preferably
Figure BDA0002802810550000164
L21And L22Independently of one another, H or F, preferably L21The expression "F" is used to indicate that,
X2represents halogen, haloalkyl or alkoxy having 1 to 3C atoms, or haloalkenyl or alkenyloxy having 2 or 3C atoms, preferably F, Cl, -OCF3,-O-CH2CF3,-O-CH=CH2,-O-CH=CF2or-CF3Very particular preference is given to F, Cl, -O-CH ═ CF2or-OCF3
m represents 0,1,2 or 3, preferably 1 or 2, and particularly preferably 1,
R3has the pair R2One or more of the meanings given for H, an unfluorinated or fluorinated alkyl or unfluorinated or fluorinated alkoxy group having 1 to 17 carbon atoms or an unfluorinated or fluorinated alkenyl group having 2 to 15C atoms, an unfluorinated or fluorinated alkenyloxy group or an unfluorinated or fluorinated alkoxyalkyl group wherein one or more CH's are present2The radicals may be
Figure BDA0002802810550000171
Figure BDA0002802810550000172
Instead, an alkyl group, an alkoxy group, a fluorinated alkyl group or a fluorinated alkoxy group having 1 to 7 carbon atoms, an alkenyl group, an alkenyloxy group, an alkoxyalkyl group or a fluorinated alkenyl group having 2 to 7 carbon atoms is preferred, and an alkyl group or an alkenyl group is preferred,
Figure BDA0002802810550000173
independently of one another at each occurrence the above
Figure BDA0002802810550000174
One of the meanings given and preferably
Figure BDA0002802810550000175
Figure BDA0002802810550000176
More preferably
Figure BDA0002802810550000181
L31And L32Independently of one another, H or F, preferably L31The expression "F" is used to indicate that,
X3represents halogen, haloalkyl or alkoxy having 1 to 3C atoms, or halogen having 2 or 3C atomsAlkenylene or alkenyloxy, preferably F, Cl, -OCF3,-OCHF2,-O-CH2CF3,-O-CH=CF2,-O-CH=CH2or-CF3Very particular preference is given to F, Cl, -O-CH ═ CF2,-OCHF2or-OCF3
Z3represents-CH2CH2-,-CF2CF2-, -COO-, trans-CH-, trans-CF-, -CH2O-or a single bond, preferably-CH2CH2-, -COO-, trans-CH-or a single bond and very preferably-COO-, trans-CH-or a single bond, and
n represents 0,1,2 or 3, preferably 1,2 or 3 and particularly preferably 1, and
c) optionally one or more compounds selected from compounds of formulae IV and V, preferably dielectrically neutral:
Figure BDA0002802810550000182
wherein
R41And R42Independently of one another, have the above for R under formula II2Given meanings, preferably R41Represents alkyl and R42Represents alkyl or alkoxy or R41Represents alkenyl and R42Represents an alkyl group, and is represented by,
Figure BDA0002802810550000183
independently of each other and if
Figure BDA0002802810550000184
Two occurrences, then these also have the above pairs independently of one another
Figure BDA0002802810550000191
One of the meanings given and preferably denotes
Figure BDA0002802810550000192
Preference is given to
Figure BDA0002802810550000193
Is represented by one or more of
Figure BDA0002802810550000194
Z41And Z42Independently of each other and if Z41Two occurrences, then these also represent independently of one another-CH2CH2-, -COO-, trans-CH-, trans-CF-, -CH2O-,-CF2O-, -C.ident.C-or a single bond, preferably one or more thereof represents a single bond, and
p represents 0,1 or 2, preferably 0 or 1,
R51and R52Independently of one another have the formula for R41And R42One of the meanings given and preferably denotes alkyl having 1 to 7 carbon atoms, preferably n-alkyl, particularly preferably n-alkyl having 1 to 5 carbon atoms, alkoxy having 1 to 7 carbon atoms, preferably n-alkoxy, particularly preferably n-alkoxy having 2 to 5 carbon atoms, alkoxyalkyl having 2 to 7C atoms, preferably having 2 to 4C atoms, alkenyl or alkenyloxy, preferably alkenyloxy,
Figure BDA0002802810550000201
if present, each independently of the other, have the above pairs
Figure BDA0002802810550000202
One of the meanings given and preferably denotes
Figure BDA0002802810550000203
Preference is given to
Figure BDA0002802810550000204
Preference is given to
Figure BDA0002802810550000205
To represent
Figure BDA0002802810550000206
And, if present
Figure BDA0002802810550000207
Preferred expression(s)
Figure BDA0002802810550000208
Z51To Z53Each independently of the other represents-CH2-CH2-,CH2-O-, -CH ≡ CH-, -C ≡ C-, -COO-or a single bond, preferably-CH-, -C ≡ C-, -COO-or a single bond2-CH2-,-CH2-O-or a single bond, and particularly preferably a single bond,
i and j each independently of the other represent 0 or 1,
(i + j) preferably represents 0,1 or 2, more preferably 0 or 1, and most preferably 1,
d) again optionally, alternatively or additionally, one or more compounds selected from compounds of formulae VI to IX, preferably dielectrically negative:
Figure BDA0002802810550000211
wherein
R61,R62,R71,R72,R81And R82Independently of one another, have the above for R41And R42One of the meanings given, preferably
R61Denotes unsubstituted alkyl having 1 to 7C atoms, preferably straight-chain alkyl, more preferably n-alkyl, most preferablyPropyl or pentyl, unsubstituted alkenyl having 2 to 7C atoms, preferably straight-chain alkenyl, particularly preferably having 2 to 5C atoms, unsubstituted alkoxy having 1 to 6C atoms or unsubstituted alkenyloxy having 2 to 6C atoms,
R62represents an unsubstituted alkyl group having 1 to 7C atoms, an unsubstituted alkoxy group having 1 to 6C atoms or an unsubstituted alkenyloxy group having 2 to 6C atoms, and
l represents a number of 0 or 1,
R71denotes unsubstituted alkyl having 1 to 7 carbon atoms, preferably straight-chain alkyl, more preferably n-alkyl, most preferably propyl or pentyl, or unsubstituted alkenyl having 2 to 7C atoms, preferably straight-chain alkenyl, particularly preferably having 2 to 5C atoms,
R72represents an unsubstituted alkyl group having from 1 to 7 carbon atoms, preferably having from 2 to 5 carbon atoms, an unsubstituted alkoxy group having from 1 to 6 carbon atoms, preferably having 1,2,3 or 4C atoms, or an unsubstituted alkenyloxy group having from 2 to 6C atoms, preferably having 2,3 or 4C atoms,
R81denotes unsubstituted alkyl having 1 to 7 carbon atoms, preferably straight-chain alkyl, more preferably n-alkyl, most preferably propyl or pentyl, or unsubstituted alkenyl having 2 to 7C atoms, preferably straight-chain alkenyl, particularly preferably having 2 to 5C atoms,
R82represents an unsubstituted alkyl group having from 1 to 7 carbon atoms, preferably having from 2 to 5 carbon atoms, an unsubstituted alkoxy group having from 1 to 6 carbon atoms, preferably having 1,2,3 or 4C atoms, or an unsubstituted alkenyloxy group having from 2 to 6C atoms, preferably having 2,3 or 4C atoms, and
Figure BDA0002802810550000221
to represent
Figure BDA0002802810550000222
Figure BDA0002802810550000223
To represent
Figure BDA0002802810550000224
Preference is given to
Figure BDA0002802810550000231
More preferably
Figure BDA0002802810550000232
Z8Represents- (C ═ O) -O-, -CH2-O-,-CF2-O-or-CH2-CH2-, preferably- (C ═ O) -O-or-CH2-O-, and
o represents a number of 0 or 1,
R91and R92Independently of one another have the above for R72The meaning given is that of the compounds,
R91preferably represents an alkyl group having 2 to 5 carbon atoms, preferably having 3 to 5 carbon atoms,
R92preferably represents an alkyl group or an alkoxy group having 2 to 5 carbon atoms, more preferably an alkoxy group having 2 to 4 carbon atoms, or an alkenyloxy group having 2 to 4 carbon atoms.
Figure BDA0002802810550000233
To represent
Figure BDA0002802810550000234
p and q independently of one another denote 0 or 1, and
(p + q) preferably represents 0 or 1, and
Figure BDA0002802810550000235
to represent
Figure BDA0002802810550000236
In the case of (1), alternatively, it is preferable that p ═ q ═ 1,
e) optionally again, one or more compounds of the formula IN having a high dielectric constant perpendicular to the director and parallel to the director, preferably IN a concentration IN the range from 1% to 60%, more preferably IN the range from 5% to 40%, particularly preferably IN the range from 8% to 35%,
Figure BDA0002802810550000237
wherein
Figure BDA0002802810550000238
To represent
Figure BDA0002802810550000241
Figure BDA0002802810550000242
To represent
Figure BDA0002802810550000243
n represents a number of 0 or 1,
R11and R12Independently of one another, represents alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, preferably alkenyl having 1 to 7 carbon atoms, having 2 to 7 carbon atoms, alkenyloxy, alkoxyalkyl or fluorinated alkenyl, and preferably alkyl, alkoxy, alkenyl or alkenyloxy, most preferably alkyl, alkoxy or alkenyloxy, and R11May alternatively represent R1And R is12May alternatively represent X1
R1Denotes alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, preferably having 1 to 7C atoms, one of which is-CH2The radical-may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, preferably cyclopropylene or 1, 3-cyclopentylene, alkenyl having from 2 to 7 carbon atoms, alkenyloxy, alkoxyalkyl or fluorinated alkenyl, in which one-CH-group2The radical may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, preferably cyclopropylene or 1, 3-cyclopentylene, and preferably alkyl or alkenyl,
1, 3-cyclopentenylene is a moiety selected from the group of the formula:
Figure BDA0002802810550000244
preference is given to
Figure BDA0002802810550000251
More preferably
Figure BDA0002802810550000252
And
X1denotes F, Cl, fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy or fluorinated alkenyloxy, the latter four radicals preferably having 1 to 4C atoms, preferably F, Cl, CF3Or OCF3In particular F is preferred for formulae I-1 and I-2 and OCF is preferred for formula I-43And
f) optionally again, one or more compounds of the formula B having a high dielectric constant perpendicular to the director and parallel to the director, preferably in a concentration in the range from 1% to 60%, more preferably in the range from 5% to 40%, particularly preferably in the range from 8% to 35%,
Figure BDA0002802810550000253
wherein
Figure BDA0002802810550000254
To represent
Figure BDA0002802810550000255
Figure BDA0002802810550000256
To represent
Figure BDA0002802810550000257
RB1And RB2Independently of one another, represents alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, preferably having 1 to 7C atoms, one of which is-CH2The radical-may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, preferably cyclopropylene or 1, 3-cyclopentylene, alkenyl having from 2 to 7 carbon atoms, alkenyloxy, alkoxyalkyl or fluorinated alkenyl, in which one-CH-group2The radical may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, preferably cyclopropylene or 1, 3-cyclopentylene, and is preferably alkyl, alkoxy, alkenyl or alkenyloxy, most preferably alkyl, alkoxy or alkenyloxy, and
n represents 0 or 1, preferably 0.
g) Optionally again, one or more compounds of the formula S having a high dielectric constant perpendicular to the director and parallel to the director, preferably in a concentration in the range from 1% to 60%, more preferably in the range from 5% to 40%, particularly preferably in the range from 8% to 35%,
Figure BDA0002802810550000261
wherein
Figure BDA0002802810550000262
To represent
Figure BDA0002802810550000263
Figure BDA0002802810550000264
To represent
Figure BDA0002802810550000265
RS1And RS2Independently of one another, represents alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, preferably having 1 to 7C atoms, one of which is-CH2The radical-may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, preferably cyclopropylene or 1, 3-cyclopentylene, alkenyl having from 2 to 7 carbon atoms, alkenyloxy, alkoxyalkyl or fluorinated alkenyl, in which one-CH-group2The radical may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, preferably cyclopropylene or 1, 3-cyclopentylene, and is preferably alkyl, alkoxy, alkenyl or alkenyloxy, most preferably alkyl, alkoxy or alkenyloxy, and
n represents 0 or 1, preferably 1.
The liquid-crystalline medium according to the present application preferably has a nematic phase.
In the compounds of the formula I, the radical N (R)13)(R14) Amines may also be preferred.
Preferred are the following embodiments:
p is a number of 2 and,
Figure BDA0002802810550000271
is an organic radical having 4 binding sites, preferably an alkanetetrayl unit having 1 to 30C atoms, where the radicals R are present in addition to m radicals R in the molecule12Besides, but independently thereof, one other H atom may also be replaced by R12Instead of or in addition to one or more other H atoms, may also be substituted by R12Instead, preference is given to having a mono-or divalent alkanetetrayl unit on each of the two terminal C atoms, one of which is-CH2A group or a plurality of-CH2The radicals-may be replaced by-O-or- (C ═ O) -in such a way that the two O atoms are not bonded directly to one another, or substituted or unsubstituted aromatic or heteroaromatic hydrocarbon radicals having a valency of up to 8, where R is present in the molecule in addition to the m radicals present in the molecule12Furthermore, but independently thereof, one other H atom may be replaced by R12Instead of or in addition to one or more other H atoms, may be replaced by R12Instead of this, the user can,
Figure BDA0002802810550000272
to represent
Figure BDA0002802810550000273
(biphenyl-1, 1 ', 3, 3' -diyl),
Figure BDA0002802810550000274
(benzene-1, 2,4, 5-diyl),>CH-[CH2]r-CH<(where r ∈ {0,1,2,3,4,5 to 18}, -CH2-(CH-)-[CH2]q-(CH-)-CH2-<(where q ∈ {0,1,2,3,4,5 to 16},
Figure BDA0002802810550000281
to represent
Figure BDA0002802810550000282
(benzene-1, 3, 5-triyl),
Figure BDA0002802810550000283
(benzene-1, 2, 4-triyl) or>CH-[CH2]r-CH2- (where r ∈ {0,1,2,3,4,5 to 18}) or
Figure BDA0002802810550000284
represents-CH2-[CH2]r-CH2- (where r. epsilon. {0,1,2,3,4,5 to 18}), octane-1, 8-diyl, heptane-1, 7-diyl, hexane-1, 6-diyl, pentane-1, 5-diyl, butane-1, 4-diyl, propane-1, 3-diyl, ethane-1, 2-diyl, or
Figure BDA0002802810550000285
(1, 4-phenylene group),
Figure BDA0002802810550000286
(1, 3-phenylene group),
Figure BDA0002802810550000287
(1, 2-phenylene) or
Figure BDA0002802810550000288
(1, 4-cyclohexylidene).
In an alternative preferred embodiment of the process according to the invention,
p represents 1.
In the present application, all elements contain their corresponding isotopes. In particular, one or more H in the compound may be replaced by D, and this is also particularly preferred in some embodiments. The corresponding highly deuteration of the corresponding compound enables, for example, monitoring and identification of the compound. This can be very helpful in some cases, especially in the case of compounds of formula I.
In the context of the present application, it is,
alkyl particularly preferably denotes straight-chain alkyl, in particular CH3-,C2H5-,n-C3H7-,n-C4H9-or n-C5H11-, and
alkenyl particularly preferably represents CH2=CH-,E-CH3-CH=CH-,CH2=CH-CH2-CH2-,E-CH3-CH=CH-CH2-CH2-,E-(n-C3H7)-CH=CH-。
The liquid-crystalline media according to the application preferably comprise a total of from 1ppm to 2500ppm, preferably from 1ppm to 1500ppm, preferably from 1 to 600ppm, even more preferably from 1 to 250ppm, preferably to 200ppm, and very particularly preferably from 1ppm to 100ppm, of compounds of the formula I.
In a preferred embodiment of the present invention, in the compounds of formula I,
Figure BDA0002802810550000289
to represent
Figure BDA00028028105500002810
(Biphenyl-1, 1 ', 3, 3' -diyl)
Figure BDA0002802810550000291
(benzene-1, 2,4, 5-diyl)
Figure BDA0002802810550000292
To represent
Figure BDA0002802810550000293
(benzene-1, 3, 5-triyl) or
Figure BDA0002802810550000294
(benzene-1, 2, 4-triyl),
Figure BDA0002802810550000295
is represented by- (CH)2-)2,-(CH2-)3,-(CH2-)4,-(CH2-)5,-(CH2-)6,-(CH2-)7,-(CH2-)8I.e. ethane-1, 2-diyl, propane-1, 3-diyl, butane-1, 4-diyl, pentane-1, 5-diyl, hexane-1, 6-diyl, heptane-1, 7-diyl, octane-1, 8-diyl,
Figure BDA0002802810550000296
(1, 4-phenylene group),
Figure BDA0002802810550000297
(1, 3-phenylene group),
Figure BDA0002802810550000298
(1, 2-phenylene) or
Figure BDA0002802810550000299
(trans-1, 4-cyclohexylidene), and/or
-Z12-S11-Z11-represents, independently of one another at each occurrence, -O-, S11-O-,-O-S11-O-,-(C=O)-O-S11-O-,-O-(C=O)-S11-O-,-O-(C=O)-S11-(C=O)-O-,-O-S11-(C=O)-O-,-(C=O)-O-S11-C,-(C=O)-O-S11-O- (C ═ O) -or- (N-R)13)-S11-O-,-(N-R13-C(=O)-S11- (C ═ O) -O or a single bond, preferably-O-, -S11-O-,-O-S11-O-,-(C=O)-O-S11-O,-O-(C=O)-S11-O-or-O-S11- (C ═ O) -O-, and/or
S11Preferably represents an alkylene group having 1 to 20C atoms, and/or
R11If present, represents alkyl, alkoxy or H, preferably H or alkyl, and/or
R12Represents H, methyl, ethyl, propyl, isopropyl or 3-heptyl, or cyclohexyl.
In a preferred embodiment of the present application, in the compounds of the formula I,
Figure BDA00028028105500002910
represents a group selected from the following formulae
Figure BDA0002802810550000301
In a preferred embodiment of the present application, in the compounds of the formula I,
Figure BDA0002802810550000302
represents a group selected from the following formulae
Figure BDA0002802810550000303
In a preferred embodiment of the present application, in the compounds of formula I, wherein p preferably represents 1,
Figure BDA0002802810550000304
to represent
Figure BDA0002802810550000305
preferably-O-S11-O-,-S11-O-or-O-S11-O-S is particularly preferred11-O-or-S11-O-。
In a further preferred embodiment of the present application, in the compounds of the formula I,
Figure BDA0002802810550000311
preferably represents a group selected from the following formulae
Figure BDA0002802810550000312
In a further preferred embodiment of the present application, where p is 2, which may be the same or different from those described above, in the compounds of formula I,
Figure BDA0002802810550000321
preferably represents a group selected from the following formulae
Figure BDA0002802810550000322
In a further preferred embodiment of the present application, which may be identical to or different from those described above, in the compounds of the formula I the radicals
Figure BDA0002802810550000331
Represent independently of each other at each occurrence
Figure BDA0002802810550000332
Preference is given to
Figure BDA0002802810550000333
In a particularly preferred embodiment of the present application, in the compounds of the formula I, all radicals present are
Figure BDA0002802810550000334
Have the same meaning.
These compounds are very suitable as stabilizers in liquid-crystal mixtures. In particular, they stabilized the VHR of the mixture against UV exposure.
In a preferred embodiment of the present invention, the media according to the invention comprise in each case one or more compounds of the formula I selected from the following group of compounds of the formulae I-1 to I-13: preferably selected from the compounds of the formulae I-3, I-5, I-6, I-7, I-8, I-9, I-10, I-12 and I-13, particularly preferably from the compounds of the formulae I-6 to I-10 and very particularly preferably from the compounds of the formula I-10,
Figure BDA0002802810550000341
Figure BDA0002802810550000351
Figure BDA0002802810550000361
Figure BDA0002802810550000371
Figure BDA0002802810550000381
in an even more preferred embodiment of the present invention, the media according to the invention comprise in each case one or more compounds of the formula I selected from the compounds of the formulae I-1 and/or I-3 to I-8 and/or I-9 and/or I-10 below.
In an even more preferred embodiment of the present invention, the media according to the invention comprise in each case one or more compounds of the formula I selected from the compounds of the formulae I-9 and/or I-10 below.
In addition to the compounds of the formula I or preferred subformulae thereof, the media according to the invention preferably also comprise one or more compounds of the formula II in a total concentration of from 1% or more to 90% or less, preferably from 10% or more to 80% or less, particularly preferably from 20% or more to 70% or less.
In a preferred embodiment of the present invention, the liquid-crystalline medium comprises one or more compounds selected from the group consisting of formula II-1 and formula II-2, preferably dielectrically positive, preferably having a dielectric anisotropy of 3 or more:
Figure BDA0002802810550000391
wherein the parameters have the respective meanings indicated above under formula II, and L23And L24Independently of one another, H or F, preferably L23Represents F, and
Figure BDA0002802810550000392
has the advantages of
Figure BDA0002802810550000393
One of the meanings given and, in the case of the formulae II-1 and II-2, X2Preferably represents F or OCF3F is particularly preferred, and in the case of formula II-2,
Figure BDA0002802810550000394
independently of one another, preferably represent
Figure BDA0002802810550000395
Figure BDA0002802810550000396
In addition to the compounds of the formula I or preferred subformulae thereof, the media according to the invention preferably comprise one or more compounds of the formula III in a total concentration of from 1% or more to 40% or less, preferably from 3% or more to 20% or less, particularly preferably from 4% or more to 10% or less.
The compound of formula III is preferably selected from compounds of formulae III-1 and III-2:
Figure BDA0002802810550000397
Figure BDA0002802810550000401
wherein the parameters have the meanings given under formula III and the media according to the invention can comprise one or more compounds of the formula III-3 in place of or in addition to the compounds of the formula III-1 and/or III-2
Figure BDA0002802810550000402
Wherein the parameters have the respective meanings indicated above, and the parameter L31And L32Independently of each other and independently of the other parameters, H or F.
The liquid-crystalline medium preferably comprises a compound selected from the group consisting of the formulae II-1 and II-2, where L21And L22And/or L23And L24Both represent F.
In a preferred embodiment, the liquid-crystalline medium comprises a compound selected from the group consisting of the formulae II-1 and II-2, where L21,L22,L23And L24Both represent F.
The liquid-crystalline medium preferably comprises one or more compounds of the formula II-1. The compound of formula II-1 is preferably selected from compounds of formulae II-1a to II-1e, preferably one or more compounds of formulae II-1a and/or II-1b and/or II-1d, preferably of formulae II-1a and/or II-1d or II-1b and/or II-1d, most preferably of formulae II-1 d:
Figure BDA0002802810550000403
Figure BDA0002802810550000411
wherein the parameters have the respective meanings indicated above, and L25And L26Independently of one another and of other parameters, H or F, and preferably, in the formulae II-1a and II-1b, L21And L22Both represent F, in the formulae II-1c and II-1d, L21And L22All represent F and/or L23And L24Both represent F, and in the formula II-1e, L21,L22And L23Represents F.
The liquid-crystalline medium preferably comprises one or more compounds of the formula II-2, which are preferably selected from the group consisting of compounds of the formulae II-2a to II-2k, preferably one or more compounds each of the formulae II-2a and/or II-2h and/or II-2 j:
Figure BDA0002802810550000412
Figure BDA0002802810550000421
Figure BDA0002802810550000431
wherein the parameters have the respective meanings indicated above, and L25To L28Independently of one another, H or F, preferably L27And L28All represent H, particularly preferably L26Represents H.
The liquid-crystalline medium preferably comprises a compound selected from the group consisting of the formulae II-1a to II-1e, where L21And L22All represent F and/or L23And L24Both represent F.
In a preferred embodiment, the liquid-crystalline medium comprises a compound selected from the group consisting of the formulae II-2a to II-2k, where L21,L22,L23And L24Both represent F.
Particularly preferred compounds of the formula II-2 are those of the formula II-2a-1 and/or II-2h-1 and/or II-2 k-2:
Figure BDA0002802810550000432
Figure BDA0002802810550000441
Figure BDA0002802810550000451
wherein R is2And X2Has the meaning indicated above, and X2Preferably represents F.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-1. The compound of formula III-1 is preferably selected from compounds of formulae III-1a to III-1j, preferably from formulae III-1c, III-1f, III-1g and III-1 j:
Figure BDA0002802810550000452
Figure BDA0002802810550000461
Figure BDA0002802810550000471
wherein the parameters have the meanings given above, and preferably wherein the parameters have the corresponding meanings indicated above, the parameter L35And L36H or F, independently of one another and of the other, and a parameter L35And L36Independently of each other and of the other parameters, H or F.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-1c, which are preferably selected from compounds of the formulae III-1c-1 to III-1c-5, preferably of the formulae III-1c-1 and/or III-1c-2, most preferably of the formula III-1 c-1:
Figure BDA0002802810550000472
Figure BDA0002802810550000481
wherein R is3Have the meaning indicated above.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-1f, which are preferably selected from the group consisting of compounds of the formulae III-1f-1 to III-1f-6, preferably of the formulae III-1f-1 and/or III-1f-2 and/or III-1f-3 and/or III-1f-6, more preferably of the formulae III-1 f-6:
Figure BDA0002802810550000482
Figure BDA0002802810550000491
wherein R is3Have the meaning indicated above.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-1g, which are preferably selected from compounds of the formulae III-1g-1 to III-1g-5, preferably of the formula III-1 g-3:
Figure BDA0002802810550000492
Figure BDA0002802810550000501
wherein R is3Have the meaning indicated above.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-1h, which are preferably selected from compounds of the formulae III-1h-1 to III-1h-3, preferably of the formula III-1 h-3:
Figure BDA0002802810550000502
wherein the parameters have the meanings given above, and X3Preferably represents F.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-1i, which are preferably selected from the group consisting of compounds of the formulae III-1i-1 and III-1i-2, preferably of the formula III-1 i-2:
Figure BDA0002802810550000503
wherein the parameters have the meanings given above, and X3Preferably represents F.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-1j, which are preferably selected from the group consisting of compounds of the formulae III-1j-1 and III-1j-2, preferably of the formula III-1 j-1:
Figure BDA0002802810550000511
wherein the parameters have the meanings given above.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-2. The compound of formula III-2 is preferably selected from compounds of formulae III-2a and III-2b, preferably formula III-2 b:
Figure BDA0002802810550000512
wherein the parameters have the respective meanings indicated above, and the parameter L33And L34Independently of each other and of the other parameters, H or F.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-2a, which are preferably selected from the compounds of the formulae III-2a-1 to III-2 a-6:
Figure BDA0002802810550000513
Figure BDA0002802810550000521
wherein R is3Have the meaning indicated above.
The liquid-crystalline medium preferably comprises one or more compounds of the formula III-2b, which are preferably selected from compounds of the formulae III-2b-1 to III-2b-4, preferably of the formula III-2 b-4:
Figure BDA0002802810550000522
etherification
Figure BDA0002802810550000531
Figure BDA0002802810550000532
Wherein R is3Have the meaning indicated above.
The media according to the invention may also comprise, instead of or in addition to the compounds of the formulae III-1 and/or III-2, one or more compounds of the formula III-3
Figure BDA0002802810550000533
Wherein the parameters have the respective meanings indicated above in formula III.
These compounds are preferably selected from the formulae III-3a and III-3 b:
Figure BDA0002802810550000534
wherein R is3Have the meaning indicated above.
The liquid-crystalline medium according to the invention preferably comprises one or more dielectrically neutral compounds whose dielectric anisotropy is preferably from-1.5 to 3, preferably selected from the compounds of the formulae VI, VII, VIII and IX.
In the present application, all elements include their respective isotopes. In particular, one or more H in the compound may be replaced by D, and this is also particularly preferred in some embodiments. The corresponding highly deuterated formation of the corresponding compound enables, for example, the detection and identification of the compound. This may be very helpful in certain cases, especially in the case of the compounds of the formula I.
In the context of the present application, it is,
alkyl particularly preferably denotes straight-chain alkyl, in particular CH3-,C2H5-,n-C3H7-,n-C4H9-or n-C5H11-, and
alkenyl particularly preferably represents CH2=CH-,E-CH3-CH=CH-,CH2=CH-CH2-CH2-,E-CH3-CH=CH-CH2-CH2-or E- (n-C)3H7)-CH=CH-。
In a preferred embodiment of the present invention, the medium according to the invention comprises one or more compounds of the formula B, preferably of the formula B-1, preferably in a concentration of from 1% to 20%, particularly preferably from 2% to 15% and very particularly preferably from 3% to 9%,
Figure BDA0002802810550000541
wherein the parameters have the respective meanings given above under formula B, and preferably
RB1And RB2In each case independently of one another represent unsubstituted alkyl, alkoxy, oxaalkyl or alkoxyalkyl having 1 to 7C atoms or alkenyl or alkenyloxy having 2 to 7C atoms, preferably both represent alkoxy, and
LB1and LB2In each case independently of one another, F or Cl, preferably F.
In a particularly preferred embodiment, the medium according to the invention comprises one or more compounds selected from the group consisting of the compounds of the formulae OH-1 to OH-6,
Figure BDA0002802810550000542
Figure BDA0002802810550000551
these compounds are very suitable for stabilizing media against thermal loads.
In a further preferred embodiment of the present invention, in which the media according to the invention comprise in particular one or more compounds of the formula I in which p represents 2 and n represents 2,3 or 4, preferably 2 or 3, particularly preferably 3, these media have excellent stability.
In a further preferred embodiment of the present invention, the media according to the invention comprise at least one or more compounds of the formula I in each case, in which p represents 1 and n represents 3,4,5 or 6, preferably 4, and the radical-Z11-S11-Z12-represents an omega-dioxyalkylene group, i.e. -O-S11O-these media have excellent stability.
The invention also relates to an electro-optical display or an electro-optical component comprising a liquid-crystalline medium according to the invention. Preferably electro-optical displays based on the IPS, FFS, VA or ECB effect, preferably based on the IPS or FFS effect, and in particular those addressed by active matrix addressing means.
The invention therefore likewise relates to the use of the liquid-crystalline media according to the invention IN electro-optical displays or electro-optical components, and to a process for the preparation of the liquid-crystalline media according to the invention, which is characterized IN that one or more compounds of the formula I are mixed with one or more compounds of the formula II, preferably with one or more compounds of the sub-formula II-1, and with one or more further compounds, preferably selected from the compounds of the formulae III and IV and/or V and/or VI to IX and/or IN and/or B and/or S.
Furthermore, the present invention relates to a method for stabilizing a liquid-crystalline medium comprising one or more compounds of the formula II and one or more compounds selected from the group consisting of the compounds of the formulae III to IX, B, S and IN, characterized IN that one or more compounds of the formula I are added to the medium.
In a particularly preferred embodiment, the medium comprises one or more compounds of the formula IV selected from the group consisting of the compounds of the formulae IV-1 to IV-4, preferably of the formulae IV-1 and/or IV-2,
Figure BDA0002802810550000561
wherein
alkyl and alkyl' independently of one another denote alkyl having 1 to 7C atoms, preferably 2 to 5C atoms,
alkinyl and alkinyl', independently of one another, denote alkenyl having 2 to 5C atoms, preferably having 2 to 4C atoms, particularly preferably 2C atoms.
alkenyl' denotes alkenyl having 2 to 5C atoms, preferably having 2 to 4C atoms, particularly preferably having 2 to 3C atoms, and
alkoxy denotes alkoxy having 1 to 5C atoms, preferably having 2 to 4C atoms.
In a particularly preferred embodiment, the medium according to the invention comprises one or more compounds of the formula IV-1 and/or one or more compounds of the formula IV-2.
Particularly preferred compounds of formula IV-1 are compounds selected from the group consisting of
Figure BDA0002802810550000571
Wherein alkyl has the meaning given above, and preferably represents in each case independently of one another an alkyl group having 1 to 6, preferably having 2 to 5, C atoms, and particularly preferably an n-alkyl group.
Particularly preferred compounds of the formula IV are those selected from the group consisting of
Figure BDA0002802810550000572
Figure BDA0002802810550000581
In another preferred embodiment, the medium comprises one or more compounds of formula V, which are selected from the group consisting of compounds of formulae V-1 to V-11, preferably from the group consisting of compounds of formulae V-1 to V-5,
Figure BDA0002802810550000582
Figure BDA0002802810550000591
wherein the parameters have the meanings given above under formula V, and
Y5represents H or F, and preferably
R51Represents an alkyl group having 1 to 7C atoms or an alkenyl group having 2 to 7C atoms, and
R52denotes alkyl having 1 to 7C atoms, alkenyl having 2 to 7C atoms or alkoxy having 1 to 6C atoms, preferably alkyl or alkenyl, particularly preferably alkenyl.
In another preferred embodiment, the medium comprises one or more compounds of formula V-1, which are selected from the group consisting of compounds of formulae V-1a and V-1b, preferably of formula V-1b,
Figure BDA0002802810550000592
wherein
alkyl and alkyl' independently of one another denote alkyl having 1 to 7C atoms, preferably 2 to 5C atoms,
alkoxy denotes alkoxy having 1 to 5C atoms, preferably having 2 to 4C atoms.
In another preferred embodiment, the medium comprises one or more compounds of formula V-3, which are selected from the group consisting of compounds of formulae V-3a and V-3b,
Figure BDA0002802810550000601
wherein
alkyl and alkyl' independently of one another denote alkyl having 1 to 7C atoms, preferably having 2 to 5C atoms, and
alkenyl denotes alkenyl having 2 to 7C atoms, preferably having 2 to 5C atoms.
In another preferred embodiment, the medium comprises one or more compounds of formula V-4, which are selected from the group consisting of compounds of formulae V-4a and V-4b,
Figure BDA0002802810550000602
wherein
alkyl and alkyl' independently of one another denote alkyl having 1 to 7C atoms, preferably having 2 to 5C atoms.
In another preferred embodiment, the medium comprises one or more compounds of formula V-5, which are selected from compounds of formulae V-5a to V5d, preferably of formulae V-5a and/or V-5b,
Figure BDA0002802810550000611
wherein
alkyl and alkyl' independently of one another denote alkyl having 1 to 7C atoms, preferably having 2 to 5C atoms, and
alkinyl and alkinyl', independently of one another, denote alkenyl having 2 to 5C atoms, preferably having 2 to 4C atoms, particularly preferably 4C atoms.
The liquid-crystalline medium according to the invention may comprise one or more chiral compounds.
Particularly preferred embodiments of the present invention satisfy one or more of the following conditions, wherein acronyms (abbreviations) are explained in tables a to C and are illustrated by way of example in table D.
i. The birefringence of the liquid-crystalline medium is 0.060 or more, particularly preferably 0.070 or more.
The birefringence of the liquid-crystalline medium is 0.130 or less, particularly preferably 0.120 or less.
The birefringence of the liquid-crystalline medium is in the range of 0.090 or higher to 0.120 or lower.
The liquid-crystalline medium has a negative dielectric anisotropy having a value of 2.0 or more, particularly preferably 3.0 or more.
v. the liquid-crystalline medium has a negative dielectric anisotropy which has a value of 5.5 or less, particularly preferably 5.0 or less.
The liquid crystal medium has a negative dielectric anisotropy having a value in the range of 3.6 or more to 5.2 or less.
The total concentration of compounds of formula II in the entire mixture is 25% or more, preferably 30% or more, and preferably in the range of 25% or more to 49% or less, particularly preferably in the range of 29% or more to 47% or less, and very particularly preferably in the range of 37% or more to 44% or less.
The liquid-crystalline medium comprises one or more compounds of formula IV, which are selected from the compounds of the following formulae: CC-n-V and/or CC-n-Vm, particularly preferably CC-3-V, preferably in a concentration of at most 50% or less, particularly preferably at most 42% or less, and optionally additionally CC-3-V1, preferably in a concentration of at most 15% or less, and/or CC-4-V, preferably in a concentration of at most 20% or less, particularly preferably at most 10% or less.
The total concentration of compounds of formula CC-3-V throughout the mixture is 20% or higher, preferably 25% or higher.
The proportion of the compounds of the formulae II and III in the entire mixture is 10% or more, and preferably 75% or less.
Liquid-crystalline media consist essentially of, preferably consist of, compounds of the formulae I, II, III, IV, V and B and/or S.
The invention furthermore relates to an electro-optical display with active matrix addressing based on the VA or ECB effect, which is characterized in that it contains a liquid-crystalline medium according to the invention as a dielectric.
The liquid-crystal mixture preferably has a nematic phase range having a width of at least 80 degrees and at most 30mm at 20 DEG C2·s-1Flow viscosity v of20
The liquid-crystal mixtures according to the invention have a Δ ∈ of from-0.5 to-8.0, in particular from-1.5 to-6.0, and very particularly preferably from-2.0 to-5.0, where Δ ∈ denotes the dielectric anisotropy.
Rotational viscosity gamma1Preferably 150 mPas or less, in particular 120 mPas or less and very particularly preferably 120 mPas orAnd is smaller.
The mixtures according to the invention are suitable for all IPS and FFS-TFT applications. They are also suitable for all VA applications, for example, VAN, MVA, (S) -PVA and ASV applications, and PALC applications with negative Δ ∈.
The nematic liquid-crystal mixtures in the displays according to the invention generally comprise two components A and B, which themselves consist of one or more individual compounds.
The liquid-crystalline media according to the invention preferably comprise from 4 to 15, in particular from 5 to 12 and particularly preferably 10 or fewer compounds. These are preferably selected from compounds of formulae I, II and III-1 to III-4, and/or IV and/or V.
The liquid-crystalline medium according to the invention may optionally also comprise more than 18 compounds. In this case, they preferably contain 18 to 25 compounds.
In addition to the compounds of the formulae I to V, further constituents may also be present, for example in an amount of up to 45%, but preferably up to 35%, in particular up to 10%, of the entire mixture.
The media according to the invention may optionally also comprise a dielectrically positive component, preferably in a total concentration of 10% or less, based on the entire medium.
In a preferred embodiment, the liquid-crystalline medium according to the invention comprises, based on the entire mixture, in total,
from 100ppm or more to 2500ppm or less, preferably from 300ppm or more to 2000ppm or less, particularly preferably from 500ppm or more to 1500ppm or less, and very particularly preferably from 700ppm or more to 1200ppm or less, of a compound of the formula I,
20% or more to 60% or less, preferably 25% or more to 50% or less, particularly preferably 30% or more to 45% or less of the compound of the formula II, and
50% or more to 70% or less of a compound of formulae I to IX and/or IN and/or B and/or S.
In a preferred embodiment, the liquid-crystalline medium according to the invention comprises one or more compounds selected from the group consisting of the compounds of the formulae II, III, IV, V, VI, VII, VIII and IX, preferably from the compounds of the formulae II and/or III and/or IV and/or V, which, independently of one another, comprise one or more rings selected from the group consisting of the substituted 1, 4-phenylenes
Figure BDA0002802810550000641
In a particularly preferred embodiment of the above preferred embodiments, the liquid-crystalline medium according to the invention comprises one or more compounds selected from the group consisting of
Figure BDA0002802810550000642
In a preferred embodiment, the liquid-crystalline medium according to the invention comprises one or more compounds selected from the group consisting of the compounds of the formulae II, III, IV, V, VI, VII, VIII and IX, preferably from the compounds of the formulae II and/or III and/or IV and/or V, which comprise one end group or, if present, two end groups, preferably one end group, which is selected from the group consisting of the following end groups
3-fluoropropyl, cyclopropyl, cyclopropylmethyl, 2-cyclopropylethyl, cyclobutyl, cyclobutylmethyl, cyclopentyl and cyclopentylmethyl,
preferably selected from the group consisting of 3-fluoropropyl, cyclopropyl, cyclopropylmethyl, 2-cyclopropylethyl, cyclobutylmethyl and cyclopentylmethyl.
In a particularly preferred embodiment of the above preferred embodiments, the liquid-crystalline medium according to the invention comprises one or more compounds selected from the group consisting of
Figure BDA0002802810550000651
Figure BDA0002802810550000661
Figure BDA0002802810550000671
Figure BDA0002802810550000681
Figure BDA0002802810550000691
Figure BDA0002802810550000701
Figure BDA0002802810550000711
In a preferred embodiment, the liquid-crystalline medium according to the invention comprises a compound selected from the group consisting of the compounds of the formulae I, II, III, IV, V, In, B and S, preferably from the compounds of the formulae I, II and/or III and/or B and/or S; they preferably consist predominantly, particularly preferably essentially and very particularly preferably virtually completely, of the compounds of the formula.
The liquid-crystalline media according to the invention preferably have a nematic phase which is in each case at least-20 ℃ or less to 70 ℃ or more, particularly preferably-30 ℃ or less to 80 ℃ or more, very particularly preferably-40 ℃ or less to 85 ℃ or more and most preferably-40 ℃ or less to 90 ℃ or more.
The expression "having a nematic phase" here means on the one hand that no smectic phases and no crystallization are observed at low temperatures at the corresponding temperatures and on the other hand that no clearing occurs on heating of the nematic phase. The studies at low temperature were carried out in a flow viscometer at the corresponding temperature and checked by storage in a test cell having a cell thickness corresponding to the electro-optical application for at least 100 hours. If the storage stability at a temperature of-20 ℃ in the corresponding test cartridge is 1000 hours or more, the medium is considered to be stable at that temperature. The corresponding times were 500 hours and 250 hours at-30 ℃ and-40 ℃ respectively. The clearing point is measured in the capillary by conventional methods at elevated temperature. In addition, the shelf life of bulk (in bulk) (1mL sample) at low temperature was determined in glass bottles at temperatures of-20 ℃ or-30 ℃. At these temperatures, preferably at-30 ℃, the stable shelf life is preferably 120 hours or more, particularly preferably 240 hours or more.
In a preferred embodiment, the liquid-crystalline medium according to the invention is characterized by an optical anisotropy in the moderate to low range. The birefringence value is preferably in the range of 0.065 or more to 0.130 or less, particularly preferably in the range of 0.080 or more to 0.120 or less, and very particularly preferably in the range of 0.085 or more to 0.110 or less.
In this embodiment, the liquid-crystalline medium according to the invention has a negative dielectric anisotropy and a relatively high absolute value of the dielectric anisotropy (| Δ ∈ |), which is preferably in the range from 2.7 or more to 5.3 or less, preferably to 4.5 or less, preferably from 2.9 or more to 4.5 or less, particularly preferably from 3.0 or more to 4.0 or less and very particularly preferably from 3.5 or more to 3.9 or less.
The liquid-crystalline medium according to the invention has a relatively low threshold voltage (V)0) A value in the range of 1.7V or more to 2.5V or less, preferably 1.8V or more to 2.4V or less, particularly preferably 1.9V or more to 2.3V or less and very particularly preferably 1.95V or more to 2.1V or less.
In a further preferred embodiment, the liquid-crystalline media according to the invention preferably have a relatively low mean dielectric anisotropy value (. epsilon.)av.≡(ε||+2ε) /3), which is preferably in the range from 5.0 or more to 7.0 or less, preferably from 5.5 or more to 6.5 or less, still more preferably from 5.7 or more to 6.4 or less, particularly preferably from 5.8 or more to 6.2 or less and very particularly preferably from 5.9 or more to 6.1 or less.
Furthermore, the liquid-crystalline media according to the invention have a high VHR value in the liquid-crystal cell.
In the case, these are preferably greater than or equal to 95%, preferably greater than or equal to 97%, particularly preferably greater than or equal to 98% and very particularly preferably greater than or equal to 99% in the case freshly filled at 20 ℃ and these are greater than or equal to 90%, preferably greater than or equal to 93%, particularly preferably greater than or equal to 96% and very particularly preferably greater than or equal to 98% after 5 minutes in the oven at 100 ℃ in the case.
Generally, here liquid-crystalline media with a low addressing voltage or threshold voltage have a lower VHR than those with a higher addressing voltage or threshold voltage, and vice versa.
These preferred values of the individual physical properties are also preferably maintained in each case by the media according to the invention being combined with one another.
In the present application, the term "compound" also written as "(one or more) compound" refers to both one and more compounds, unless explicitly stated otherwise.
Unless otherwise indicated, the individual compounds are generally used in the mixture in concentrations of from 1% or more to 30% or less, preferably from 2% or more to 30% or less and particularly preferably from 3% or more to 16% or less.
In a preferred embodiment, the liquid-crystalline medium according to the invention comprises
One or more compounds of formula I, and
one or more compounds of the formula IV, preferably selected from the group consisting of the compounds of the formulae CC-n-V and CC-n-Vm, preferably CC-3-V, CC-3-V1, CC-4-V and CC-5-V, particularly preferably from the compounds CC-3-V, CC-3-V1 and CC-4-V, very particularly preferably the compound CC-3-V, and optionally additionally one or more compounds CC-4-V and/or CC-3-V1.
In a preferred embodiment, the liquid-crystalline medium according to the invention comprises:
one or more compounds of formula I and/or
One or more compounds of formula II, preferably of formula PUQU-n-F, CDUQU-n-F, APUQU-n-F, DPUQU-n-F and PGUQU-n-F and/or
One or more compounds of formula III, preferably of formula CCG-n-FCCP-n-OT, CLP-n-T, CGG-n-F, CGG-n-OD and PPGU-n-F and/or
One or more compounds of formula IV, preferably of formula CC-n-V, CC-n-Vm, CC-n-m, CC-V-V, CCVC-n-V and/or
One or more compounds of formula V, preferably of formula CP-n-Om, CCP-n-m, CCP-V-n, CCP-V2-n, CLP-V-n, CCVC-n-V, CGP-n-m, PGP-n-m, PGP-n-mV and CPGP-n-m and/or
Optionally, preferably essentially, one or more compounds of the formula VI, preferably of the formula Y-n-Om, Y-nO-Om and/or CY-n-Om, selected from the group consisting of the formulae Y-3-O1, Y-4O-O4, CY-3-O2, CY-3-O4, CY-5-O2 and CY-5-O4 and/or
Optionally, preferably essentially, one or more compounds of formula VII-1, preferably selected from the group consisting of compounds of formula CCY-n-m and CCY-n-Om, preferably of formula CCY-n-Om, preferably selected from the group consisting of compounds of formula CCY-3-O2, CCY-2-O2, CCY-3-O1, CCY-3-O3, CCY-4-O2, CCY-3-O2 and CCY-5-O2, and/or
Optionally, preferably essentially, one or more compounds of formula VII-2, preferably of formula CLY-n-Om, preferably selected from the group consisting of formula CLY-2-O4, CLY-3-O2, CLY-3-O3 and/or
One or more compounds of formula VIII, preferably of formula CZY-n-On and CCOY-n-m and/or
One or more compounds of formula IX, preferably selected from compounds of formula PYP-n-m and PGIY.n-Om and/or
One or more compounds of formula B and/or
One or more compounds of formula S and/or
Optionally, preferably essentially, one or more compounds of the formula IV, preferably selected from the group consisting of the compounds of the formulae CC-n-V, CC-n-Vm and CC-nV-Vm, preferably CC-3-V, CC-3-V1, CC-4-V, CC-5-V and CC-V-V, particularly preferably from the compounds CC-3-V, CC-3-V1, CC-4-V and CC-V-V, very particularly preferably the compound CC-3-V, and optionally additionally one or more compounds CC-4-V and/or CC-3-V1 and/or CC-V-V.
In a particularly preferred embodiment of the invention, the medium according to the invention comprises one or more compounds of the formula PPGU-n-F. The compounds of the formula PPGU-n-F are also very suitable as stabilizers in liquid-crystal mixtures.
In a particularly preferred embodiment of the present invention, the medium according to the invention comprises one or more compounds of the formula IX.
The compounds of the formula IX are also very suitable as stabilizers in liquid-crystal mixtures, in particular when p ═ q ═ 1 and ring A9In the case of 1, 4-phenylene. In particular, they stabilized the VHR of the mixture for UV exposure.
In a preferred embodiment, the medium according to the invention comprises one or more compounds of the formula IX, selected from one or more of the compounds of the formulae IX-1 to IX-4, very particularly preferably of the formulae IX-1 to IX-3,
Figure BDA0002802810550000751
wherein the parameters have the meanings given under formula IX and F/H denotes F or H.
In another preferred embodiment, the medium comprises one or more compounds of the formula IX-3, preferably of the formula IX-3-a,
Figure BDA0002802810550000752
alkyl and alkyl' independently of one another denote alkyl having 1 to 7C atoms, preferably having 2 to 5C atoms.
In case compounds of formula IX are used in the liquid crystalline medium according to the present application, they are preferably present in a concentration of 20% or less, more preferably 10% or less, most preferably 5% or less and for the individual compounds, i.e. (homologous) compounds, the concentration is preferably 10% or less and more preferably 5% or less.
For the purposes of the present invention, in each case, the following definitions relate to the description of the constituents of the composition, unless otherwise stated:
- "comprises": the concentration of the component in question in the composition is preferably 5% or more, particularly preferably 10% or more, very particularly preferably 20% or more,
- "consists essentially of …": the concentration of the component in question in the composition is preferably 50% or more, particularly preferably 55% or more and very particularly preferably 60% or more,
- "consists essentially of …": the concentration of the component in question in the composition is preferably 80% or more, particularly preferably 90% or more and very particularly preferably 95% or more, and
- "consists practically completely of …": the concentration of the component in question in the composition is preferably 98% or more, particularly preferably 99% or more and very particularly preferably 100.0%.
This applies to the medium as a composition with its ingredients (which may be both components and compounds), and also to the components with their ingredients (compounds). The term "comprising" only when referring to the concentration of the individual compounds relative to the entire medium means that the concentration of the compound in question is preferably 1% or more, particularly preferably 2% or more, very particularly preferably 4% or more.
For the purposes of this invention, "≦" means less than or equal to, preferably less than, and "≧" means greater than or equal to, preferably greater than.
With respect to the present invention, it is,
Figure BDA0002802810550000761
represents a trans-1, 4-cyclohexylene group,
Figure BDA0002802810550000762
represents 1, 4-cyclohexylene, preferably trans-1, 4-cyclohexylene, and
Figure BDA0002802810550000763
represents a1, 4-phenylene group.
For the purposes of the present invention, the expression "dielectrically positive compounds" means compounds having a. DELTA.. epsilon.of >1.5, the expression "dielectrically neutral compounds" generally means those in which-1.5. ltoreq. DELTA.. epsilon.ltoreq.1.5 and the expression "dielectrically negative compounds" means those in which. DELTA.. epsilon. -1.5. The dielectric anisotropy of the compounds here was determined in each case by dissolving 10% of the compound in a liquid-crystalline host and measuring the capacitance of the resulting mixture at 20 ℃ at a frequency of 1kHz in at least one test cell with homeotropic alignment and with a cell thickness of 20 μm with homeotropic alignment. The measurement voltage is usually 1.0V, but always below the capacitance threshold of the respective liquid-crystal mixture under study.
The host mixture for dielectrically positive and dielectrically neutral compounds was ZLI-4792 and the host mixture for dielectrically negative compounds was ZLI-2857, both from Merck KGaA, Germany. The values of the respective compounds to be investigated are obtained from the change in the dielectric constant of the host mixture after addition of the compound to be investigated and extrapolation to 100% of the compound employed. The compound to be investigated is dissolved in the host mixture in an amount of 10%. If the solubility of the substance is too low for this purpose, the concentration is reduced by half step by step until the study can be carried out at the desired temperature.
The compounds of the formula I according to the invention or the compounds of the formula I used according to the invention can advantageously be prepared according to the following reaction schemes.
Synthesis scheme 1:
Figure BDA0002802810550000781
wherein n preferably represents 2,3 or 4, particularly preferably 3 or 4.
Synthesis scheme 2:
Figure BDA0002802810550000791
wherein n preferably represents 2,3 or 4, particularly preferably 3 or 4.
Synthesis scheme 3:
Figure BDA0002802810550000801
wherein m represents an integer of 3 to 6, particularly preferably 4 or 6.
In the above reaction schemes, Pg represents a protecting group and Rg represents a leaving group, and the parameter n has the meaning given in the case of formula I, furthermore, R1With respect to R in the case of formula I11The ring structures have the meanings given for ZG in the case of formula I, Sp1And Sp2Respectively having the pair S in the case of formula I1And S2The meanings given, and preferably n represents 3 or 4, the ring structure represents an aromatic or aliphatic group, Sp1And Sp2Represents a single bond or an alkylene group having 1 to 8C atoms, and R1Represents an alkyl group having 1 to 8C atoms.
For the purposes of the present invention, in each case, the following definitions relate to the description of the constituents of the composition, unless otherwise stated:
- "comprises": the concentration of the component in question in the composition is preferably 5% or more, particularly preferably 10% or more, very particularly preferably 20% or more,
- "consists essentially of …": the concentration of the component in question in the composition is preferably 50% or more, particularly preferably 55% or more and very particularly preferably 60% or more,
- "consists essentially of …": the concentration of the component in question in the composition is preferably 80% or more, particularly preferably 90% or more and very particularly preferably 95% or more, and
- "consists practically completely of …": the concentration of the component in question in the composition is preferably 98% or more, particularly preferably 99% or more and very particularly preferably 100.0%.
This applies to the medium as a composition with its ingredients (which may be both components and compounds), and also to the components with their ingredients (compounds). The term "comprising" only when referring to the concentration of the individual compounds relative to the entire medium means that the concentration of the compound in question is preferably 1% or more, particularly preferably 2% or more, very particularly preferably 4% or more.
For the purposes of this invention, "≦" means less than or equal to, preferably less than, and "≧" means greater than or equal to, preferably greater than.
With respect to the present invention, it is,
Figure BDA0002802810550000811
represents trans-1, 4-cyclohexylene, and
Figure BDA0002802810550000812
represents a1, 4-phenylene group.
For the purposes of the present invention, the expression "dielectrically positive compounds" means compounds having a. DELTA.. epsilon.of >1.5, the expression "dielectrically neutral compounds" means those in which-1.5. ltoreq. DELTA.. epsilon.ltoreq.1.5 and the expression "dielectrically negative compounds" means those in which. DELTA.. epsilon. -1.5. The dielectric anisotropy of the compounds here was determined in each case by dissolving 10% of the compound in a liquid-crystalline host and measuring the capacitance of the resulting mixture at 1kHz in at least one test cell with homeotropic alignment and with a cell thickness of 20 μm with homeotropic alignment. The measurement voltage is usually 0.5V to 1.0V, but always below the capacitance threshold of the respective liquid-crystal mixture under investigation.
The host mixture for dielectrically positive and dielectrically neutral compounds was ZLI-4792 and the host mixture for dielectrically negative compounds was ZLI-2857, both from Merck KGaA, Germany. The values of the respective compounds to be investigated are obtained from the change in the dielectric constant of the host mixture after addition of the compound to be investigated and extrapolation to 100% of the compound employed. The compound to be investigated is dissolved in the host mixture in an amount of 10%. If the solubility of the substance is too low for this purpose, the concentration is reduced by half step by step until the study can be carried out at the desired temperature.
The liquid-crystalline media according to the invention may also comprise further additives, such as stabilizers and/or pleochroic dyes and/or chiral dopants, if necessary in the usual amounts. The amount of these additives used is preferably from 0% or more to 10% or less in total, particularly preferably from 0.1% or more to 6% or less, based on the amount of the entire mixture. The concentration of the individual compounds employed is preferably from 0.1% or more to 3% or less. The concentration of these and similar additives is generally not considered when specifying the concentration and concentration range of the liquid-crystalline compound in the liquid-crystalline medium.
In a preferred embodiment, the liquid-crystalline medium according to the invention comprises a polymer precursor comprising one or more reactive compounds, preferably reactive mesogens, and, if necessary, further additives, such as a polymerization initiator and/or a polymerization moderator, in the usual amounts. The amount of these additives employed is in total 0% or more to 10% or less, preferably 0.1% or more to 2% or less, based on the amount of the whole mixture. The concentrations of these and similar additives are not taken into account when specifying the concentration and concentration range of the liquid-crystalline compound in the liquid-crystalline medium.
The compositions consist of a plurality of compounds, preferably 3 or more to 30 or less, particularly preferably 6 or more to 20 or less and very particularly preferably 10 or more to 16 or less compounds, which are mixed in a conventional manner. Generally, the desired amount of the component used in lesser amounts is dissolved in the component making up the major component of the mixture. This is advantageously carried out at elevated temperatures. Completion of the dissolution operation is particularly easily observed if the temperature chosen is above the clearing point of the main component. However, it is also possible to prepare the liquid-crystal mixtures in other conventional ways, for example using premixing or from so-called "multi-bottle systems".
The mixtures according to the invention exhibit a very broad nematic phase range of clearing points at 65 ℃ or more, a very favorable capacitance threshold, relatively high retention values and at the same time very good low-temperature stability at-30 ℃ and-40 ℃. Furthermore, the mixtures according to the invention are characterized by a low rotational viscosity γ1
It is obvious to the person skilled in the art that the media according to the invention for VA, IPS, FFS or PALC displays may also comprise compounds in which, for example, H, N, O, Cl, F have been replaced by the corresponding isotopes.
The structure of the liquid crystal display according to the invention corresponds to a general geometry, as described for example in EP-a 0240379.
The liquid-crystalline phases according to the invention can be modified by suitable additives in such a way that they can be used in any type of LCD displays disclosed hitherto, such as ECB, VAN, IPS, GH or ASM-VA.
Table E below shows possible dopants that can be added to the mixtures according to the invention. If the mixture contains one or more dopants, it (they) are used in amounts of from 0.01% to 4%, preferably from 0.1% to 1.0%.
The stabilizers which can be added to the mixtures according to the invention, for example, in amounts of preferably from 0.01% to 6%, in particular from 0.1% to 3%, are shown below in table F.
For the purposes of the present invention, all concentrations are indicated in weight percent unless explicitly stated otherwise, and reference is made to the corresponding mixtures or mixture components unless explicitly stated otherwise.
Unless explicitly stated otherwise, all temperature values indicated in the present application, such as melting point T (C, N), transition T (S, N) from smectic (S) to nematic (N) phase and clearing point T (N, I), are expressed in degrees celsius (° C), and all temperature differences are correspondingly expressed in degrees difference (° or degrees).
For the purposes of the present invention, the term "threshold voltage" refers to the capacitive threshold (V), unless explicitly stated otherwise0) Also known as Freedericks threshold.
In each case, unless explicitly stated otherwise, all Physical Properties are and have been determined in accordance with "Merck Liquid Crystals, Physical Properties of Liquid Crystals", Status 1997, 11 months, Merck KGaA, Germany and with a temperature of 20 ℃ applicable, and Δ n at 589nm and Δ ε at 1 kHz.
As switching behaviour, electro-optical properties, e.g. threshold voltage (V)0) (capacitive measurement) was measured in a test cartridge prepared by Merck Japan. The measurement cell has a soda lime glass substrate and is constructed in an ECB or VA configuration (SE-1211 (mixing ratio 1:1) using diluent x 26, both from Nissan Chemicals, japan) with polyimide alignment layers that have rubbed perpendicular to each other and affected the homeotropic alignment of the liquid crystals. The surface area of the transparent, almost square ITO electrode was 1cm2
Unless otherwise stated, no chiral dopant is added to the liquid-crystal mixture used, but the latter is also particularly suitable for applications in which this type of doping is necessary.
VHR was determined in a test cassette produced by Merck Japan. The measuring cell has soda lime glass substrates and is constructed using polyimide alignment layers with a layer thickness of 50nm that have been rubbed perpendicular to each other (e.g. AL-3046 from Japan Synthetic Rubber, Japan, unless otherwise stated) or with alignment layers described in the examples that have been rubbed perpendicular to each other. The layer thickness was uniform 6.0 μm. The surface area of the transparent ITO electrode was 1cm2
VHR at 20 ℃ (VHR)20) And at 100 ℃ (VHR)100) After 5 minutes in an oven as determined in an instrument commercially available from Autronic Melchers, Germany. The voltage used has a frequency of 60Hz, or the conditions shown in the examples.
The accuracy of the VHR measurements depends on the corresponding values of VHR. The accuracy decreases with decreasing value. The deviations usually observed in the case of values in various order of magnitude ranges are compiled in the table below in terms of their order of magnitude.
Figure BDA0002802810550000841
Figure BDA0002802810550000851
In a commercial instrument from Heraeus, GermanyThe stability to UV radiation was investigated in the instrument "Suntest CPS". The sealed test box was irradiated for 2.0 hours without additional heating. The irradiation power in the wavelength range of 300nm to 800nm was 765W/m2V, or the conditions indicated in the examples. To simulate the so-called window glass mode, a UV "cut" filter with an edge wavelength of 310nm was used. In each series of experiments, at least four test cartridges were studied for each condition and the corresponding results were expressed as the average of the corresponding individual measurements.
The reduction in voltage holding ratio (Δ VHR), which is typically caused by exposure to light, for example by UV irradiation of an LCD backlight, can be determined according to the following equation (1):
ΔVHR(t)=VHR(t)-VHR(t=0) (1).
the relative stability (S) of the LC mixture to the load at time t is determined according to equation (2) belowrel):
Figure BDA0002802810550000852
Where "ref" represents the corresponding unstable mixture.
Another characteristic quantity which can characterize the conductivity of a liquid-crystal mixture in addition to VHR is the ion density. High values of ion density often result in display failures such as image sticking and flicker. The ion density is preferably determined in a test cartridge produced by Merck Japan ltd. The test cartridge has a substrate made of soda lime glass and is designed as a polyimide alignment layer with a polyimide layer thickness of 40nm (e.g. AL-3046 from Japan Synthetic Rubber, Japan, unless otherwise specified). The thickness of the liquid-crystal mixture layer was 6.0. mu.m. The area of the round transparent ITO electrode equipped with a protective ring is 1cm2. The accuracy of the measurement method is about ± 15%. The cells were dried overnight in an oven at 120 ℃ and then filled with the relevant liquid crystal mixture.
Ion density was measured using an instrument commercially available from TOYO, Japan. The Measurement method is essentially a cyclic voltammetry-like Measurement method, as described in M.Inoue, "Recent Measurement of Liquid Crystal Material Characteristics", Proceedings IDW 2006, LCT-7-1, 647. In this method, the applied direct voltage is varied between a positive and a negative maximum value according to a pre-specified triangular curve. Thus, a complete run through the curve forms one measurement cycle. If the applied voltage is large enough to enable ions in the field to move to the corresponding electrode, an ion current is formed due to the discharge of the ions. The amount of charge transferred here is generally in the range of a few pC to a few nC. This necessitates a highly sensitive detection ensured by the above-mentioned instruments. The results are shown as current/voltage curves. The ion current here is evident by the appearance of a peak at a voltage which is less than the threshold voltage of the liquid-crystal mixture. Integration of the peak areas gives the value of the ion density of the mixture studied. Four cartridges were measured for each mixture. The triangular voltage has a repetition frequency of 0.033Hz, a measurement temperature of 60 ℃ and a maximum voltage of + -3V to + -10V, depending on the order of magnitude of the dielectric anisotropy of the relevant mixture.
Rotational viscosity was measured using a rotating permanent magnet method and flow viscosity was measured in a modified ubbelohde viscometer. For the liquid-crystal mixtures ZLI-2293, ZLI-4792 and MLC-6608 (all from Merck KGaA, Darmstadt, Germany), the rotational viscosity values determined at 20 ℃ were 161mPa s, 133mPa s and 186mPa s, respectively, and the flow viscosity values (v) were 21mm, respectively2·s-1、14mm2·s-1And 27mm2·s-1
Unless explicitly stated otherwise, the following notations are used:
V0represents the capacitance [ V ] at 20 DEG C]A threshold voltage;
nerepresents the extraordinary refractive index measured at 20 ℃ and 589nm,
norepresents the ordinary refractive index measured at 20 ℃ and 589nm,
Δ n represents the optical anisotropy measured at 20 ℃ and 589nm,
εrepresenting the dielectric polarizability perpendicular to the director at 20 c and 1kHz,
ε||representing the dielectric polarizability parallel to the director at 20 c and 1kHz,
deltaε represents the dielectric anisotropy at 20 ℃ and 1kHz,
cl.p. or
T (N, I) represents clearing point [ ° C ],
v represents the flow viscosity [ mm ] measured at 20 ℃2·s-1],
γ1Represents the rotational viscosity [ mPas ] measured at 20 DEG C],
K1The elastic constant [ pN ] representing the deformation "stretched" at 20 ℃],
K2The elastic constant [ pN ] representing the "distortion" at 20 ℃ of the strain],
K3The elastic constant [ pN ] representing the "bending" deformation at 20 ℃]And are and
LTS denotes the low temperature stability of the phase measured in the test cell,
VHR represents the voltage holding ratio of the voltage holding ratio,
Δ VHR represents a decrease in the voltage holding ratio, an
SrelIndicating the relative stability of VHR.
The following examples illustrate the invention without limiting it. However, they show the person skilled in the art the concept of using preferred mixtures of the compounds to be employed preferably and their respective concentrations and also their combinations with one another. Furthermore, the examples illustrate the properties and combinations of properties that can be obtained.
For the purposes of the present invention and in the examples which follow, the structures of the liquid-crystalline compounds are indicated by means of acronyms and are converted into chemical formulae in accordance with the following tables A to C. All radicals CnH2n+1,CmH2m+1And ClH2l+1Or CnH2n,CmH2mAnd ClH2lAre straight-chain alkyl or alkylene radicals, in each case having n, m and l C atoms. Table a shows the code for the ring elements of the compound core, table B lists the bridging units, and table C lists the symbolic meanings of the left and right hand end groups of the molecule. The acronym consists of having an optional linking groupFollowed by a first hyphen and left hand end base code, and a second hyphen and right hand end base code. Table D shows exemplary structures of the compounds and their respective abbreviations.
TABLE A Ring elements
Figure BDA0002802810550000871
Figure BDA0002802810550000881
Figure BDA0002802810550000891
Figure BDA0002802810550000901
Figure BDA0002802810550000911
Figure BDA0002802810550000921
Table B: bridging unit
Figure BDA0002802810550000922
TABLE C end groups
Figure BDA0002802810550000923
Figure BDA0002802810550000931
Figure BDA0002802810550000932
Where n and m are each integers and the three points are placeholders for other abbreviations from the table.
In addition to the compounds of the formula I, the mixtures according to the invention preferably also comprise one or more of the compounds mentioned below.
The following abbreviations are used:
(n, m and z are each, independently of one another, an integer, preferably from 1 to 6)
Table D
Figure BDA0002802810550000941
Figure BDA0002802810550000951
Figure BDA0002802810550000961
Figure BDA0002802810550000971
Figure BDA0002802810550000981
Figure BDA0002802810550000991
Figure BDA0002802810550001001
Figure BDA0002802810550001011
Figure BDA0002802810550001021
Figure BDA0002802810550001031
Figure BDA0002802810550001041
Figure BDA0002802810550001051
Figure BDA0002802810550001061
Figure BDA0002802810550001071
Figure BDA0002802810550001081
Figure BDA0002802810550001091
Table E shows the chiral dopants preferably used in the mixtures according to the invention.
TABLE E
Figure BDA0002802810550001092
Figure BDA0002802810550001101
Figure BDA0002802810550001111
In a preferred embodiment of the present invention, the medium according to the present invention comprises one or more compounds selected from the compounds of table E.
Table F shows that, in addition to the compounds of the formula I, stabilizers which can preferably also be used in the mixtures according to the invention are indicated. Where the parameter n represents an integer ranging from 1 to 12. In particular, the phenolic derivatives shown can be used as additional stabilizers, since they act as antioxidants.
TABLE F
Figure BDA0002802810550001112
Figure BDA0002802810550001121
Figure BDA0002802810550001131
Figure BDA0002802810550001141
Figure BDA0002802810550001151
In a preferred embodiment of the present invention, the medium according to the invention comprises one or more compounds selected from the compounds of table F, in particular one or more compounds selected from the following two formulae.
Figure BDA0002802810550001152
Examples
The following examples illustrate the invention without limiting it in any way. However, the physical properties make it clear to the skilled person what properties can be achieved and within what ranges they can be varied. In particular, the combination of the various properties which can be preferably achieved is thus well defined for the person skilled in the art.
Examples of materials
The following substances are preferred substances of the formula I according to the present application or substances of the formula I preferably used according to the present application.
Figure BDA0002802810550001153
Figure BDA0002802810550001161
Figure BDA0002802810550001171
Figure BDA0002802810550001181
Figure BDA0002802810550001191
Figure BDA0002802810550001201
Figure BDA0002802810550001211
The following examples illustrate the invention without limiting it in any way. However, the physical properties will make it clear to the skilled person what properties are to be achieved and within what ranges they may be varied. In particular, the combination of the various properties which can be preferably achieved is thus well defined for the person skilled in the art.
Synthesis example 1:bis (2,2,6, 6-tetramethylpiperidin-4-yl) 2- {3- [2, 5-bis ({ 4-butyl-5- [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy)]-4- { [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy]Carbonyl } -5-oxopentyl }) phenyl]Synthesis of propyl } -2-butylmalonate 1
(substance example 1)
Figure BDA0002802810550001212
Step 1.1: synthesis of 3- [3, 4-bis (3-hydroxypropyl) phenyl ] propan-1-ol A
Figure BDA0002802810550001221
51.34g (484.0mmol) of anhydrous sodium carbonate were dissolved in 171.7ml of water. A solution of 25.0g (79.0mmol) of 1,2, 4-tribromobenzene and 67.70g (476.0mmol) of 2-butoxy-1, 2-oxacyclopentane in 965.2ml of Tetrahydrofuran (THF) was added, 1.65ml (11.9mmol) of triethylamine were added and the mixture was stirred and degassed with a stream of argon for 30 min. 1.40g (7.49mmol) of palladium (II) chloride (59% palladium, anhydrous) and 1.85g (3.97mmol) of 2-dicyclohexylphosphino-2 ', 6 ' -diisopropoxy-1, 1 ' -biphenyl were added and the reaction mixture was stirred under reflux for 18 hours. The reaction mixture was cooled to Room Temperature (RT), water and methyl tert-butyl ether (MTBE) were added and the phases separated. The aqueous phase was extracted with MTBE and the combined organic phases were washed with saturated NaCl solution, dried over sodium sulfate, filtered and evaporated in vacuo. The product was obtained as a light yellow oil and filtered through silica gel with a mixture of Ethyl Acetate (EA) and methanol (9: 1). The product fractions were combined and evaporated in vacuo to give the reaction product as a pale yellow oil. The product was characterized by NMR spectroscopy.
1H NMR(500MHz,DMSO-d6)
δ=1.66(mc,6H,CH2),2.42–2.69(m(superposition with DMSO),6H,CH2,),3.36–3.49(m,6H,CH2),4.44(t,J=5.15Hz,1H),4.48(mc,2H),6.92(dd,J=1.7,7.72Hz,1H),6.95(d,J=1.53Hz,1H),7.03(d,J=7.7Hz,1H)。
Step 1.2: synthesis of 1,2, 4-tri (3-iodopropyl) benzene B
Figure BDA0002802810550001222
30.2ml (138mmol) of triphenylphosphine were dissolved in 513ml of acetonitrile and a solution of 34.92g (138.0mmol) of iodine in 513ml of acetonitrile was added dropwise with gentle cooling. An orange suspension formed during this addition. When the addition was complete, the mixture was stirred for a further 10 min. 13.3g (197mmol) of imidazole are added and subsequently a solution of 10.0g (39.3mmol) of triol A in 100ml of acetonitrile is added dropwise (a clear yellow solution forms during this addition). The reaction solution was stirred at RT for 3 hours (h) and carefully poured into cold sodium thiosulfate solution (discoloration occurred) and heptane was added. After washing by stirring, the phases were separated, the aqueous phase was extracted with heptane and the combined organic phases were washed with water, dried over sodium sulfate, filtered and evaporated in vacuo. The crude product was filtered through silica gel with heptane (H) and ethyl acetate (8:2) and the product fractions were evaporated to give the product as a colorless oil. The product was characterized by mass spectrometry.
MS(EI)=582.0
Step 1.3: synthesis of 2-butylmalonyl dichloride C
Figure BDA0002802810550001231
76.00g (474.5mmol) of 2-butylmalonic acid are initially introduced into the reaction apparatus and warmed to 40 ℃. Then 90.00ml (1.240mol) of thionyl chloride (cautiously, releasing the gas) was added dropwise over the course of about 30 minutes and the mixture was stirred at Room Temperature (RT) for a further 5 hours (h). During this time period, the release of gas is significantly reduced. The reaction solution was then stirred at 50 ℃ for 18 hours and subsequently at 70 ℃ for 5 hours. At each temperature rise, a slight gas evolution occurs again. The reaction mixture was then cooled to room temperature and dissolved in 300ml of anhydrous toluene and the excess thionyl chloride was separated off together with toluene by distillation (8mBar, RT to maximum bath temperature 80 ℃) to give the crude product as a brownish liquid which was used directly in the next synthesis step.
Step 1.4: synthesis of bis (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) 2-butylmalonate D
Figure BDA0002802810550001241
45.3g (262.9mmol) 4-hydroxy-2, 2,6, 6-tetramethylpiperidine 1-oxyl (radical) and 40.1ml (289.15mmol) triethylamine are dissolved in 419ml Dichloromethane (DCM) and cooled to-11 ℃. A solution of 25.9g (131.4mmol) of acid chloride C in 252ml DCM was then added dropwise over the course of 1.5 hours (h) at-11 deg.C to-6 deg.C. The reaction mixture was stirred at maximum 0 ℃ for about 3h, thawed slowly and stirred at Room Temperature (RT) for 18 h. Adding saturated NaHCO at 3-6 deg.C under cooling3The solution, the mixture was stirred briefly and the phases separated. The aqueous phase was extracted with DCM and the organic phases were combined, washed with saturated NaCl solution, dried over sodium sulfate, filtered and evaporated in vacuo. The resulting crude product (orange solid) was filtered through silica gel with DCM/MTBE (9:1) and the product fractions were evaporated in vacuo to give the product as orange crystals.
Step 1.5: synthesis of bis (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) 2- {3- [2, 5-bis ({ 4-butyl-5- [ (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] -4- { [ (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] carbonyl } -5-oxopentyl }) phenyl ] propyl } -2-butylmalonate 1
Figure BDA0002802810550001242
0.31g (7.87mmol) of sodium hydride (60% suspension in paraffin oil) was suspended in 9.7ml of N, N-Dimethylformamide (DMF). A solution of 3.75g (7.87mmol) of diradical D in 29.0ml DMF (releasing gas) is added dropwise with gentle cooling and the mixture is stirred at RT for 1 hour. To the reaction solution, 1.40g (2.39mmol) of triiodide B was added dropwise (5 minutes exotherm 5 ℃ C.), and the mixture was stirred at room temperature for 3 hours. The reaction mixture was carefully added to the ammonium chloride solution and extracted with MTBE. The phases were separated, the aqueous phase was extracted with MTBE, washed with saturated NaCl solution, dried over sodium sulfate, filtered and evaporated in vacuo. The resulting orange crude product was filtered through silica gel with ethyl acetate/heptane (1:1) and the product fractions were evaporated in vacuo to give the product as an orange solid which bubbled in a glassy manner. The product had the following properties.
Phase (1): glass transition Temperature (TG) 23.5 deg.C, decomposition starting from 150 deg.C
MS(APCI)=1605.1[M+H+]。
Step 1.6: synthesis of bis (2,2,6, 6-tetramethylpiperidin-4-yl) 2- {3- [2, 5-bis ({ 4-butyl-5- [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy ] -4- { [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy ] carbonyl } -5-oxopentyl }) phenyl ] propyl } -2-butylmalonate 1
Figure BDA0002802810550001251
1.5g (0.1mmol) of the hexavalent radical 1' are dissolved in 20ml of THF, and 1.5g of sponge nickel (Johnson-Matthey A-7000) are added. The mixture was stirred under a hydrogen pressure of 5bar at 50 ℃ for 17 hours. The reaction solution was cooled to room temperature, filtered and evaporated in vacuo. The crude product obtained is subjected to column chromatography on basic alumina (RediSep Rf) in a CombiFlash apparatusThe process was purified with dichloromethane/methanol (95: 5), and the product fractions were combined and evaporated in vacuo. The product was placed in a bulb tube set at 50 ℃ and 3.2 x 10-1Drying at mbar for 3 hours gave the product as a foamy glassy solid.
Phase (1): tg (glass transition temperature) 39 ℃ C (melting point) 41 ℃ C.I (isotropy).
MS(APCI)=1515.1[M+H]+
1H NMR(500MHz,CDCl3)
δ=0.54–0.99(m(overlapping),16H,6X NH,CH2),1.09–1.40(m(overlapping)97H,CH3,CH2),1.48(mc,6H,CH2),1.82–2.02(m(overlapping),24H,CH2),2.57(t,J=7.63Hz,6H),5.24(mc,6H,CH(CH2)2),6.93(d(overlapping with a single multiplet),J=7.87Hz,2H),7.04(d,J=7.72Hz,1H)。
Synthesis example 2:bis (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) 2- (3- {3, 5-bis [ ({ 4-butyl-5- [ (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] oxy]-4- { [ (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy]Carbonyl } -5-oxopentyl } oxy) carbonyl]Synthesis of benzoyloxy } propyl) -2-butylmalonate 2
Figure BDA0002802810550001261
Step 2.1: bis (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) 2-butyl-2- [3-, (
Figure BDA0002802810550001262
Alk-2-yloxy) propyl]Synthesis of malonate E
Figure BDA0002802810550001271
3.20g (80.01mmol) of sodium hydride (60% suspension in paraffin oil) are suspended in 30ml of DMF. A solution of 32.40g (69.14mmol) of diradical D (from the synthesis of compound 1) in 300ml of DMF was added dropwise to the reaction solution (evolution of gas) under gentle cooling and the mixture was stirred at room temperature for 1 hour. A solution of 19.0g (85.16mmol) of 2- (3-bromopropoxy) tetrahydropyran in 200ml of DMF (exotherm 0.5 ℃ C.) is then added dropwise at RT. To degas the reaction mixture before the temperature was increased, a gentle stream of argon was passed through the reaction mixture for 30 minutes by means of a submerged pasteur pipette and the mixture was subsequently stirred at 35 ℃ for 18 hours. The reaction solution was cooled to RT, added to saturated NaCl solution, extracted with MTBE and the phases separated. The aqueous phase was extracted with MTBE and the organic phases were combined, washed with saturated NaCl solution, dried over sodium sulfate, filtered and evaporated in vacuo to give the crude product as a red oil which was filtered through silica gel with DCM/MTBE (9:1) for purification to give the product as a red oil.
Step 2.2: synthesis of bis (1-hydroxy-2, 2,6, 6-tetramethylpiperidin-4-yl) 2-butyl-2- (3-hydroxypropyl) malonate F
Figure BDA0002802810550001272
36.5g (56.1mmol) of the diradical E and 9.50g (55.2mmol) of toluene-4-sulfonic acid monohydrate are dissolved in a mixture of 500ml of methanol and 50ml of water and the mixture is stirred at 40 ℃ for 5 hours. The reaction solution was cooled to RT and NaHCO was used with cooling3The solution was adjusted to pH 9 and evaporated in vacuo. The aqueous residue was extracted with MTBE and the combined organic phases were washed with saturated NaCl solution, dried over sodium sulphate, filtered and evaporated in vacuo to give a red oil which was dissolved in 250ml DCM and 6.00g (55.6mmol) MnO was added2And the mixture was stirred at RT for 1 hour. (in the case of removal of the THP protecting group, the free radical is in some cases also converted into an OH compound, MnO being used2Reversing it). The reaction mixture was filtered through silica gel with DCM and evaporated in vacuo. The crude product obtained was filtered through silica gel with DCM/MTBE (7:3) and the product fractions were evaporated in vacuo to give a red oil.
Step 2.3: synthesis of bis (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) 2- (3- {3, 5-bis [ ({ 4-butyl-5- [ (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] -4- { [ (1-oxy-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] carbonyl } -5-oxopentyl } oxy) carbonyl ] -benzoyloxy } propyl) -2-butylmalonate 2
Figure BDA0002802810550001281
6.70g (11.7mmol F and 50.0mg (0.41mmol)4- (dimethylamino) pyridine are dissolved in 100ml dichloromethane at RT and the mixture is cooled to 4 ℃ then 5.00ml (36.1mmol) triethylamine is added and then a solution of 1.00g (3.77mmol)1,3, 5-benzenetricarbonyl chloride in 10ml DCM is added dropwise at 3-4 ℃ when the exotherm is complete the mixture is warmed to RT and then stirred at RT for 18h then ammonium chloride solution is added under cooling, the mixture is stirred briefly, the phases are separated and the aqueous phase is extracted with DCM, the combined organic phases are washed with dilute NaCl solution (better phase separation), dried over sodium sulfate, filtered and evaporated in vacuo to give the reaction product as a foam of red coagulability (solvadifying), for further purification the product is filtered through silica gel with DCM/MTBE (9:1 to 85:15), and the product fractions were evaporated in vacuo. The reaction product obtained was a red, solidifying foam. It has the following properties.
Phase (1): tg (glass transition temperature) 52 ℃, C (melting point) 57 ℃ I, decomposition >175 ℃.
MS(APCI)=1734。
The following compounds were prepared analogously to the one or more synthetic sequences described.
Material/synthetic example 2'
Figure BDA0002802810550001291
substance/Synthesis example 2
(formula I-7)
Figure BDA0002802810550001301
Material/synthetic example 3'
Figure BDA0002802810550001302
Phase (1): tg (glass transition temperature) -3 ℃, I (isotropy), decomposition >100 DEG C
substance/Synthesis example 3
Figure BDA0002802810550001311
Material/Synthesis example 4'
Figure BDA0002802810550001312
Phase (1): tg (glass transition temperature) 5 ℃, I (isotropic), decomposition >180 ℃.
substance/Synthesis example 4
(formula I-9)
Figure BDA0002802810550001321
Material/synthetic example 5'
Figure BDA0002802810550001322
Phase (1): tg (glass transition temperature) 5 ℃, I (isotropic), decomposition >170 ℃.
substance/Synthesis example 5
Figure BDA0002802810550001331
Material/synthetic example 6'
(formula I-13)
Figure BDA0002802810550001332
Phase (1): tg (glass transition temperature) 27 ℃ I (isotropic).
substance/Synthesis example 6
(formula I-12)
Figure BDA0002802810550001341
Material/synthetic example 7'
Figure BDA0002802810550001342
substance/Synthesis example 7
(formula I-3)
Figure BDA0002802810550001343
Phase (1): (glass transition temperature) 14 ℃ I (Isotropic)
Material/synthetic example 8'
(formula I-6)
Figure BDA0002802810550001351
substance/Synthesis example 8
Figure BDA0002802810550001352
Phase (1): tg (glass transition temperature) -3 ℃ I (Isotropic)
Material/synthetic example 9'
Figure BDA0002802810550001361
substance/Synthesis example 9
(formula I-5)
Figure BDA0002802810550001362
Phase (1): tg (glass transition temperature) -3 ℃ I (Isotropic)
Substance/synthesis example 10:4- (3- {3- [3, 5-bis ({3- [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy]Propoxy }) phenyl]-5- {3- [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy ] oxy]Synthesis of propoxy } phenoxy } propoxy) -2,2,6, 6-tetramethylpiperidine
Figure BDA0002802810550001371
Step 10.1: synthesis of 1-benzyl-2, 2,6, 6-tetramethylpiperidin-4-ol A
Figure BDA0002802810550001372
37.80ml (318.2mmol) of benzyl bromide and 100.0g (635.9mmol) of 2,2,6, 6-tetramethylpiperidin-4-ol are dissolved in 500ml of N, N-Dimethylformamide (DMF) and the mixture is stirred at 120 ℃ for 18 hours (h). The reaction solution was cooled to Room Temperature (RT) and stirred into a mixture of water and ice. The mixture was stirred for 30 minutes and the precipitated solid was filtered off with suction and extracted with methyl tert-butyl ether (MTB ether). The product solution is washed several times with saturated sodium chloride solution and the organic phase is dried over sodium sulfate, filtered and evaporated in vacuo. The resulting crystalline crude product was recrystallized from heptane/isopropanol (5: 1) at 5 ℃ and the crystals were suction filtered off and dried under vacuum at 40 ℃ for 18h to give the reaction product as a colorless crystalline solid.
Step 10.2: 1-benzyl-2, 2,6, 6-tetramethyl-4- [3-, (
Figure BDA0002802810550001373
Alk-2-yloxy) -propoxy]Synthesis of piperidine B
Figure BDA0002802810550001374
35.00g (141.5mmol) of tetramethylpiperidine A, 47.20g (211.5mmol) of 2- (3-bromopropoxytetrahydropyran) and 20.00g (62.04mmol) of tetra-n-butylammonium bromide are suspended in 270ml of toluene and 110ml (2.10mol) of sodium hydroxide solution (50%) are then added dropwise rapidly at Room Temperature (RT). The reaction mixture was stirred at 60 ℃ for 16 hours (h) and then allowed to cool to RT. The reaction mixture was carefully added to a mixture of ice water and toluene, and the phases were separated. The aqueous phase is extracted with toluene and the combined organic phases are washed with saturated sodium chloride solution, dried over sodium sulfate, filtered and evaporated in vacuo to give a yellow, partially crystalline crude product, to which 300ml of heptane are added and the mixture is stirred and filtered. The reaction product was obtained as a yellow oil in the mother liquor and filtered through silica gel with toluene/ethyl acetate (9:1 to 3: 1). The product fractions were combined and evaporated in vacuo to give the product as a pale yellow oil.
Step 10.3: synthesis of 3- [ (1-benzyl-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] propan-1-ol C
Figure BDA0002802810550001381
34.60g (80.91mmol) of B and 20.00g (116.1mmol) of toluene-4-sulfonic acid monohydrate were dissolved in 700ml of methanol and 100ml of water (exotherm/7K) were added at room temperature. The reaction solution was stirred at 40 ℃ for 1h, followed by vacuumEvaporated and diluted with methyl tert-butyl ether (MTBE). The mixture was washed with saturated NaHCO3The solution was carefully washed and the phases were separated. The organic phase was washed with saturated NaCl solution, dried over sodium sulfate, filtered and evaporated in vacuo to give the crude product as a yellow oil which was filtered through silica gel with Dichloromethane (DCM) and MTBE (3: 1). The product fractions were combined to give the reaction product as an almost colorless oil.
Step 10.4: synthesis of 1-benzyl-4- [3- (3- {3- [ (1-benzyl-2, 2,6, 6-tetramethyl-piperidin-4-yl) oxy ] propoxy ] -5-bromophenoxy } propoxy ] -2,2,6, 6-tetramethylpiperidine D
Figure BDA0002802810550001382
5.80g (30.7mmol) of 5-bromobenzene-1, 3-diol, 21.50g (70.4mmol) of the alcohol C from the preceding step and 18.51g (70.58mmol) of triphenylphosphine were dissolved in 120ml of Tetrahydrofuran (THF) and cooled to 0 ℃. 14.70ml (70.58mmol) of diisopropyl azodicarboxylate were added dropwise to the reaction solution, and the mixture was stirred at room temperature for 16 h. The reaction mixture is evaporated in vacuo, 200ml of heptane are added and the mixture is stirred vigorously. The precipitated triphenylphosphine oxide was filtered off and the mother liquor was washed with 100ml heptane and evaporated in vacuo. The crude product obtained was filtered through silica gel with heptane/MTBE (7:3) and the combined product fractions were evaporated in vacuo to give the reaction product as a viscous oil.
Step 10.5: synthesis of 1-benzyl-4- [3- (3- {3- [ (1-benzyl-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] propoxy } -5- [3, 5-bis ({3- [ (1-benzyl-2, 2,6, 6-tetramethylpiperidin-4-yl) oxy ] propoxy }) -phenyl ] phenoxy) propoxy ] -2,2,6, 6-tetramethylpiperidine E
Figure BDA0002802810550001391
14.60g (19.11mmol) of bromide D from the preceding step, 2.54g (10.0mmol) of bis (pinacolato) diboron and 2.81g (28.7mmol) of potassium acetate are initially introduced into 150ml of bis
Figure BDA0002802810550001392
Alkane and degassing atmosphere under argon for 30 minutes. 220.00mg (0.30mmol) of PdCl are added2Dppf and the reaction mixture was stirred at 100 ℃ for 1 h. Then, the mixture was cooled to a temperature below the boiling point, and 220.00mg (0.30mmol) of PdCl was added thereto2Dppf and 25ml (50mmol) of sodium carbonate solution (2M), and the mixture is stirred at 100 ℃ for 20 h. The reaction mixture was cooled to room temperature, water and MTBE were added, and the phases were separated. The aqueous phase was extracted with MTBE and the organic phases were combined, washed with water, dried over sodium sulfate, filtered and evaporated in vacuo. The crude product was obtained as a black oil and filtered through silica gel with heptane/MTBE (8:2 to 7: 3). The combined product fractions were evaporated in vacuo to give the reaction product as a yellow resin.
MS(APCI)=1367.9[M]+
1H NMR(500MHz,CDCl3)
δ=0.99(s,24H,CH3),1.13(s,24H,CH3),1.45(t,J=11.7Hz,8H,CH2),1.94(dd,J=12.25,3.84Hz,4H,CH2),2.09(quint,J=6.16Hz,4H,CH2),3.71(t(superposition with multiplet),J=6.21Hz,6H,CH2,CH),3.83(s,8H,CH2),4.15(t,6.15Hz),6.53(t,2.06Hz,2H),6.76(d,J=2.12Hz,4H),7.16(t,7.26Hz,4H),7.28(t,7.72Hz,8H),7.43(d,J=7.49Hz,8H)。
Step 10.6: synthesis of 4- (3- {3- [ 3.5-bis ({3- [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy ] propoxy }) phenyl ] -5- {3- [ (2,2,6, 6-tetramethylpiperidin-4-yl) oxy ] -propoxy } phenoxy } propoxy) -2,2,6, 6-tetramethylpiperidine 10
Figure BDA0002802810550001401
8.50g (6.21mmol) of product E from the previous step are dissolved in 107ml of tetrahydrofuran, 3.00g of 5% Pd/C (50% water, Degussa) are added and the mixture is stirred under a hydrogen atmosphere at atmospheric pressure and Room Temperature (RT) for 17 hours. The reaction mixture was filtered and evaporated in vacuo. Dissolving the residue in waterTo 100ml of MTBE, 50ml of 2N hydrochloric acid were added and the phases were separated. The aqueous phase is extracted with MTBE, then adjusted to pH 12-13 using 32% sodium hydroxide solution and extracted with MTBE ether. The combined organic phases were washed with saturated sodium chloride solution, dried over sodium sulfate, filtered and evaporated in vacuo. The crude product obtained is passed over Al with dichloromethane/methanol2O3("basic alumina") was filtered and the product fractions were combined and evaporated in vacuo to give the product as a solidified pale yellow oil.
Phase (1): tg (glass transition temperature) -4 ℃, T (C, I) (melting point) 64 ℃ I (isotropic).
MS(APCI)=1007.7[M+H]+
1H NMR(500MHz,CDCl3)
δ 0.62(s (wide), 4H, NH),1.02(t, J11.76, 8H),1.15(s,24H, CH)3),1.19(s,24H,CH3) 1.98(dd,12.49,3.9Hz 8H),2.07 (quintuple, 6.13Hz,8H),3.69 (t: (1))Overlapped),J=5.8Hz,12H),4.12(t,J=6.1Hz,8H),6.50(s(Width of)=2H),6.73(d,J=2.1Hz,4H)。
Substance/synthesis example 11:synthesis of
Figure BDA0002802810550001411
The compound was prepared similarly to give a colorless oil.
Phase (1): t isg(glass transition temperature) -118 ℃.
1H NMR(500MHz,CDCl3)
δ=6.35(dd,J=13.3,2.2Hz,6H),4.05(t,J=6.1Hz,8H),3.81–3.51(m,12),2.57–2.48(m,4H),2.04(p,J=6.2Hz,8H),1.98(dd,J=12.5,3.9Hz,8H),1.67–1.56(m,4H),1.36(d,J=4.1Hz,6H),1.18(d J=19.7Hz,48H),1.02(t,J=11.7Hz,8H),0.69(s,4H)。
Examples of mixtures
Liquid crystal mixtures having the compositions and properties shown in the following table were prepared and investigated. The improved stability of the mixtures comprising the compounds of formula I is shown by comparison with an unstabilized base mixture as reference.
Example 1 and corresponding comparative example
The following mixture (M-1) was prepared and studied.
Figure BDA0002802810550001412
Figure BDA0002802810550001421
First, the stability of the voltage holding ratio of the mixture (M-1) itself was determined. The stability of the mixture M-1 to backlight irradiation was investigated in a test cell with an alignment material for planar alignment having a layer thickness of 6.0 μ M and a flat ITO electrode. To this end, the one or more mixtures are tested for exposure to a backlight. For this reason, the stability of the respective test cell to LED (light emitting diode) backlighting for LCDs was investigated. For this purpose, the respective test cartridge is filled and sealed. The cells were then exposed to commercial LCD backlighting multiple times. No additional heat is applied other than that generated by the backlight. The "voltage holding ratio" was then determined in each case after 5 minutes at a temperature of 100 ℃. The results are summarized in the following table, table 1 a.
Here, six test cartridges were filled and studied for each individual mixture, as shown below. The indicated value is the average of six individual values.
The relative deviation of the "voltage holding ratio" values in the various measurement series is typically in the range of about 3% to 4%.
100ppm, 500ppm or 1000ppm of the reference compound R-1 are added to the other three mixtures M-1,
Figure BDA0002802810550001422
and correspondingly 100ppm, 500ppm or 1000ppm of compound I-10 are added to the other three mixtures M-1,
Figure BDA0002802810550001431
as described above, the stability of the resulting mixtures (C-1.1, C-1.2 and C-1.3 and M-1.1, M-1.2 and M-1.3) was investigated. The results are shown in the following table, tables 1a to 1 c.
TABLE 1a
Figure BDA0002802810550001432
TABLE 1b
Figure BDA0002802810550001433
Figure BDA0002802810550001441
TABLE 1c
Figure BDA0002802810550001442
Example 2 and corresponding comparative example
The following mixture (M-2) was prepared and studied.
Figure BDA0002802810550001443
Figure BDA0002802810550001451
The stability of the mixture M-2 against UV radiation with respect to its voltage holding ratio is investigated below. For this purpose, the mixture is also divided into several portions.
First, the stability of the mixture (M-2) itself was determined. For this reason, the stability of the mixture M-1 to UV exposure was investigated in test cells with a suitable polyimide as alignment material for planar alignment and flat ITO electrodes with a layer thickness of 6.0 μ M. For this, the respective test cassettes were irradiated in Suntest for 30 minutes. The voltage holding ratio was then determined in each case after 5 minutes at a temperature of 100 ℃. The addressing frequency (or measurement frequency) here is 60Hz, unless specified otherwise. The results are summarized in table 2 a.
Then, for comparison, 100ppm, 500ppm or 1000ppm of the reference compound R-1 are added to three mixtures M-2 and the resulting mixtures (C-2.1, C-2.2 and C-2.3) are investigated as described above. Then, 100ppm, 500ppm or 1000ppm of compound I-9, respectively, were added to three mixtures M-2 and the resulting mixtures (M-2.1, M-2.2 and M-2.3) were investigated as above.
Example 3
The following mixture (M-3) was prepared and studied
Figure BDA0002802810550001452
Figure BDA0002802810550001461
As described in examples 1 and 2, the mixture M-3 was also divided into several parts, and such studies as well as studies with various added compounds were performed in a test cell with a planar aligned alignment material and a planar ITO electrode for its exposure stability to LCD backlight and UV source.
Example 4
The following mixture (M-4) was prepared and studied
Figure BDA0002802810550001462
Figure BDA0002802810550001471
As described in examples 1 to 3, the mixture M-4 was also divided into several parts, and such studies as well as studies with various added compounds were carried out in a test cell with a planar aligned alignment material and a planar ITO electrode for its exposure stability to LCD backlight and UV source.
Example 5
The following mixture (M-5) was prepared and studied
Figure BDA0002802810550001472
As described in examples 1 to 4, the mixture M-5 was also divided into several parts, and such studies as well as studies with various added compounds were performed in a test cell with a planar aligned alignment material and a planar ITO electrode for its exposure stability to LCD backlight and UV source.
Example 6
The following mixture (M-6) was prepared and studied
Figure BDA0002802810550001481
As described in examples 1 to 5, the mixture M-6 was also divided into several parts, and such studies as well as studies with various added compounds were performed in a test cell with a planar aligned alignment material and a planar ITO electrode for its exposure stability to LCD backlight and UV source.

Claims (18)

1. Liquid-crystalline medium, characterised in that it comprises
a) One or more compounds of formula I
Figure FDA0002802810540000011
Wherein
R11Each occurrence independently of the others represents H, F, a linear or branched alkyl chain having 1 to 20C atoms, one of which is-CH2-a group or, if present, a plurality of-CHs2The radical-may be replaced by-O-or-C (═ O) -but no two adjacent-CH groups2The radical being replaced by-O-, and one or, if present, more than one-CH2The radicals-CH-OR-C.ident.C-may be replaced by-CH-OR-C.ident.C-and one OR more H atoms may be replaced by F, OR13,N(R13)(R14) Or R15Instead of this, the user can,
R12each occurrence independently of the others represents a straight or branched alkyl chain having 1 to 20C atoms, one of which is-CH2A group or a plurality of-CH2The radical-may be replaced by-O-or-C (═ O) -but no two adjacent-CH groups2The radical being replaced by-O-, a hydrocarbon radical comprising cycloalkyl or alkylcycloalkyl units, and in which one-CH2A group or a plurality of-CH2The radicals-may be replaced by-O-or-C (═ O) -without two adjacent-CH groups2The radical being replaced by-O-, and one OR more H atoms being able to be replaced by F, OR13,N(R13)(R14) Or R15Instead of, OR in addition to, aromatic OR heteroaromatic hydrocarbon radicals in which one OR more H atoms may be replaced by F, OR13,N(R13)(R14) Or R15Instead of this, the user can,
R13each occurrence independently of the others represents a straight-chain or branched alkyl or acyl radical having 1 to 10C atoms, or an aromatic hydrocarbon radical having 6 to 12C atoms or a carboxylic acid radical,
R14each occurrence independently of the others represents a straight-chain or branched alkyl or acyl radical having 1 to 10C atoms, or an aromatic hydrocarbon radical having 6 to 12C atoms or a carboxylic acid radical,
R15each occurrence independently of the other represents a linear or branched alkyl group having 1 to 10C atoms, one of which is-CH2A group or a plurality of-CH2The radicals-may be replaced by-O-or-C (═ O) -without two adjacent-CH groups2-radical is-an O-substitution is carried out,
S11and S12Each occurrence independently of the other represents an alkylene group having 1 to 20C atoms, one of which is-CH2-a group or, if present, a plurality of-CHs2The radicals-may be replaced by-O-or-C (═ O) -without two adjacent-CH groups2The radical being replaced by-O-, and one OR more H atoms being able to be replaced by F, OR13,N(R13)(R14) Or R15Instead of, or in addition to, a single bond,
Y11to Y14Each independently of the others represents a methyl or ethyl group,
Z11to Z14Independently of one another, each occurrence represents-O-, -C-O-O-, -C-O-, -O- (C-O) -O-, -N-R13)-,-N-R13- (C ═ O) -or if S11Is a single bond, but Z represents a single bond11And Z12Both do not represent-O-simultaneously, and, however, if S is12Is a single bond, Z13And Z14Both do not simultaneously represent-O-, and if-X11[-R11]o-is a single bond, Z12And Z13Does not simultaneously represent-O-,
X11the expression C is shown in the specification,
p represents a number of 1 or 2,
o represents (3-p),
n p represents an integer of 3 to 10
In the case where p is 1,
n represents 3,4,5, 6 or 8,
m represents (10-n), and,
in the case where p is 2,
n represents an integer of 2 to 4, and
m represents (4-n), and
Figure FDA0002802810540000021
represents an organic group having (m + n) binding sites,
and wherein, in the case where p ═ 1, -X11[-R11]oAlternatively, it is also possibleRepresents a single bond, and is a hydrogen atom,
b) one or more compounds selected from the group consisting of formula II and III,
Figure FDA0002802810540000031
wherein
R2Represents H, a non-fluorinated or fluorinated alkyl group or a non-fluorinated or fluorinated alkoxy group having 1 to 17C atoms, or a non-fluorinated or fluorinated alkenyl group having 2 to 15C atoms, a non-fluorinated or fluorinated alkenyloxy group or a non-fluorinated or fluorinated alkoxyalkyl group, wherein one or more CH are2The radicals may be
Figure FDA0002802810540000032
Instead, an alkyl group, alkoxy group, fluorinated alkyl group or fluorinated alkoxy group having 1 to 7 carbon atoms, an alkenyl group, alkenyloxy group, alkoxyalkyl group or fluorinated alkenyl group having 2 to 7 carbon atoms,
Figure FDA0002802810540000033
represent independently of each other at each occurrence
Figure FDA0002802810540000034
Wherein R isLRepresent, identically or differently on each occurrence, H or an alkyl radical having 1 to 6C atoms, or
Figure FDA0002802810540000041
L21And L22Independently of one another, represent H or F,
X2represents halogen, haloalkyl or alkoxy having 1 to 3C atoms or haloalkenyl or alkenyloxy having 2 or 3C atoms,
m represents 0,1,2 or 3,
R3represents H, a non-fluorinated or fluorinated alkyl group or a non-fluorinated or fluorinated alkoxy group having 1 to 17 carbon atoms, or a non-fluorinated or fluorinated alkenyl group having 2 to 15C atoms, a non-fluorinated or fluorinated alkenyloxy group or a non-fluorinated or fluorinated alkoxyalkyl group, wherein one or more CH are2The radicals may be
Figure FDA0002802810540000042
Figure FDA0002802810540000043
Instead of this, the user can,
Figure FDA0002802810540000044
represent independently of each other at each occurrence
Figure FDA0002802810540000045
Figure FDA0002802810540000051
Wherein R isLRepresents, identically or differently on each occurrence, H or an alkyl group having 1 to 6C atoms; or
Figure FDA0002802810540000052
L31And L32Independently of one another, represent H or F,
X3represents halogen, haloalkyl or alkoxy having 1 to 3C atoms or haloalkenyl or alkenyloxy having 2 or 3C atoms, F, Cl, -OCF3,-OCHF2,-O-CH2CF3,-O-CH=CF2,-O-CH=CH2or-CF3
Z3represents-CH2CH2-,-CF2CF2-, -COO-, trans-CH-, trans-CF-, -CH2O-or a single bond, and
n represents 0,1,2 or 3.
2. The medium according to claim 1, characterized in that the total concentration of the compound of the formula I in the entire medium is from 1ppm or more to 2000ppm or less.
3. A medium according to claim 1 or 2, characterized in that it comprises one or more compounds of formula II.
4. The medium according to one or more of claims 1 to 3, characterized in that it comprises one or more compounds of the formula III.
5. Medium according to one or more of claims 1 to 4, characterized in that it comprises one or more compounds selected from the group consisting of the compounds of formulae B and S
Figure FDA0002802810540000061
Wherein
Figure FDA0002802810540000062
To represent
Figure FDA0002802810540000063
Figure FDA0002802810540000064
To represent
Figure FDA0002802810540000065
RB1And RB2Independently of one another, represents alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, one of which is-CH2The radical-may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, alkenyl having 2 to 7 carbon atoms, alkenyloxy, alkoxyalkyl or fluorinated alkenyl, one of which is-CH2The group-may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene,
n represents a number of 0 or 1,
Figure FDA0002802810540000066
to represent
Figure FDA0002802810540000071
Figure FDA0002802810540000072
To represent
Figure FDA0002802810540000073
RS1And RS2Independently of one another, represents alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy, one of which is-CH2The radical-may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, alkenyl having 2 to 7 carbon atoms, alkenyloxy, alkoxyalkyl or fluorinated alkenyl, one of which is-CH2The group-may be replaced by cyclopropylene, 1, 3-cyclobutylene, 1, 3-cyclopentylene, 1, 3-cyclopentenylene, and
n represents 0 or 1, preferably 1.
6. Medium according to one or more of claims 1 to 5, characterized in that it comprises one or more compounds selected from the group consisting of formulae IV and V
Figure FDA0002802810540000074
Wherein
R41And R42Independently of one another, have the above meanings for R in claim 12The meaning given is that of the compounds,
Figure FDA0002802810540000075
independently of each other and if
Figure FDA0002802810540000076
These occur twice and, independently of one another, if present, each have the meanings given in claim 1 for
Figure FDA0002802810540000081
One of the meanings given is as follows,
Figure FDA0002802810540000082
Z41and Z42Independently of each other and if Z41Two occurrences, then these also represent independently of one another-CH2CH2-, -COO-, trans-CH-, trans-CF-, -CH2O-,-CF2O-, -C.ident.C-or a single bond, preferably one or more thereof represents a single bond, and
p represents a number of atoms of 0,1 or 2,
R51and R52Independently of one another, have the meanings given for R41And R42The meaning given is that of the compounds,
Figure FDA0002802810540000083
to
Figure FDA0002802810540000084
If present, each independently of the other, have the above pairs
Figure FDA0002802810540000085
One of the meanings given
Z51To Z53Each independently of the other represents-CH2-CH2-,-CH2-O-, -CH ═ CH-, -C ≡ C-, -COO-or a single bond, and
i and j each independently of the other represent 0 or 1.
7. The medium according to one or more of claims 1 to 6, characterized in that it additionally comprises one or more chiral compounds.
8. A compound of formula I
Figure FDA0002802810540000091
Wherein the parameters have the meanings given for formula I in claim 1.
9. A compound of formula I according to claim 8, wherein p represents 2.
10. A compound of formula I according to claim 9, which is a compound selected from the group consisting of formulae I-1 to I-13
Figure FDA0002802810540000092
Figure FDA0002802810540000101
Figure FDA0002802810540000111
Figure FDA0002802810540000121
Figure FDA0002802810540000131
11. Electro-optical display or electro-optical component, characterized in that it contains a liquid-crystalline medium according to one or more of claims 1 to 7.
12. A display according to claim 11, characterized in that it is based on IPS, FFS, VA or ECB effects.
13. A display as claimed in claim 11 or 12, characterised in that it comprises an active matrix addressing device.
14. Use of compounds of the formula I according to one or more of claims 8 to 10 in liquid-crystalline media.
15. Use of a liquid-crystalline medium according to one or more of claims 1 to 7 in electro-optical displays or electro-optical components.
16. Process for the preparation of a liquid-crystalline medium according to one or more of claims 1 to 7, characterized in that one or more compounds of the formula I according to one or more of claims 1 to 10 are mixed with one or more compounds of the formula II according to claim 1 and/or one or more compounds selected from the group of compounds of the formulae III-1 to III-4 according to claim 1.
17. Method for stabilizing a liquid-crystalline medium, characterized in that one or more compounds of the formula I as given in claim 1, and optionally one or more compounds selected from the group consisting of the compounds of the formulae OH-1 to OH-6, are added to the medium
Figure FDA0002802810540000141
18. Process for the preparation of compounds of the formula I according to one or more of claims 8 to 10, characterized in that alcohols containing two 1-oxo-2, 2,6, 6-tetramethylpiperidin-4-yl groups are reacted with a suitable derivatized ring structure, such as dicarboxylic acid dihalides or tetracarboxylic acid tetrahalides.
CN201980035960.2A 2018-05-30 2019-05-27 Compound and liquid-crystalline medium Pending CN112236499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18175212.2 2018-05-30
EP18175212 2018-05-30
PCT/EP2019/063560 WO2019228938A1 (en) 2018-05-30 2019-05-27 Compounds and liquid-crystalline medium

Publications (1)

Publication Number Publication Date
CN112236499A true CN112236499A (en) 2021-01-15

Family

ID=62528257

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980035960.2A Pending CN112236499A (en) 2018-05-30 2019-05-27 Compound and liquid-crystalline medium

Country Status (5)

Country Link
EP (1) EP3802731A1 (en)
KR (1) KR20210014685A (en)
CN (1) CN112236499A (en)
TW (1) TWI845512B (en)
WO (1) WO2019228938A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202200630A (en) * 2020-04-30 2022-01-01 德商馬克專利公司 Polymerizable liquid crystal material and polymerized liquid crystal film
US20220119711A1 (en) * 2020-10-19 2022-04-21 Merck Patent Gmbh Liquid-crystal medium
EP4008759A1 (en) * 2020-11-20 2022-06-08 Merck Patent GmbH Polymerisable liquid crystal material and polymerised liquid crystal film

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011013007A1 (en) * 2010-04-01 2011-10-06 Merck Patent Gmbh Liquid crystalline medium with a nematic phase and a negative dielectric anisotropy, useful in electro-optical displays or components, comprises a substituted cyclic compound and a compound comprising substituted piperidine structural unit
US20150337202A1 (en) * 2014-05-26 2015-11-26 Jnc Corporation Liquid crystal composition and liquid crystal display device
US20160032188A1 (en) * 2014-07-29 2016-02-04 Jnc Corporation Liquid crystal composition and liquid crystal display device
CN105339464A (en) * 2013-06-26 2016-02-17 捷恩智株式会社 Liquid crystal composition, and liquid crystal display element
CN106281357A (en) * 2015-05-21 2017-01-04 默克专利股份有限公司 Liquid crystal media and the liquid crystal display comprising it
CN107686462A (en) * 2016-08-05 2018-02-13 默克专利股份有限公司 Piperidine derivative and liquid crystal media

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5523169A (en) 1978-08-09 1980-02-19 Seiko Epson Corp Liquid crystal composition and display elements comprising it
FR2595157B1 (en) 1986-02-28 1988-04-29 Commissariat Energie Atomique CELL WITH A DOUBLE LAYER OF LIQUID CRYSTAL, USING THE ELECTRICALLY CONTROLLED BIREFRINGENCE EFFECT AND METHOD FOR MANUFACTURING A UNIAXIC NEGATIVE ANISOTROPY ANISOTROPY MEDIUM FOR USE IN THIS CELL
JPH05117324A (en) 1991-10-31 1993-05-14 Mitsubishi Rayon Co Ltd Liquid crystal composite, liquid crystal optical device and their production
JPH09291282A (en) 1996-04-26 1997-11-11 Sumitomo Chem Co Ltd Stabilized liquid crystal material and liquid crystal element using the same
EP1184442A1 (en) 2000-08-30 2002-03-06 Clariant International Ltd. Liquid crystal mixture
ATE523576T1 (en) 2006-07-19 2011-09-15 Merck Patent Gmbh LIQUID CRYSTALLINE MEDIUM
EP2176376B1 (en) 2007-08-15 2012-09-19 Merck Patent GmbH Liquid-crystalline medium
WO2009115186A1 (en) 2008-03-17 2009-09-24 Merck Patent Gmbh Liquid crystalline medium
KR20110005272A (en) 2008-04-22 2011-01-17 메르크 파텐트 게엠베하 Liquid crystalline medium
ATE548435T1 (en) 2008-10-30 2012-03-15 Merck Patent Gmbh LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY
CN103391985B (en) 2010-12-07 2016-03-16 默克专利股份有限公司 Liquid crystal media and electro-optic displays
EP2514800B2 (en) 2011-04-21 2018-03-07 Merck Patent GmbH Compounds and liquid crystalline medium
EP2993216B1 (en) * 2014-09-02 2017-07-26 Merck Patent GmbH Compounds and liquid crystalline medium
CN118421329A (en) 2015-03-13 2024-08-02 默克专利股份有限公司 Liquid-crystalline medium
EP3093328B1 (en) 2015-05-13 2018-06-13 Merck Patent GmbH Liquid crystalline medium
DE102018000286A1 (en) * 2017-01-30 2018-08-02 Merck Patent Gmbh COMPOUNDS AND LIQUID CRYSTALLINE MEDIUM

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011013007A1 (en) * 2010-04-01 2011-10-06 Merck Patent Gmbh Liquid crystalline medium with a nematic phase and a negative dielectric anisotropy, useful in electro-optical displays or components, comprises a substituted cyclic compound and a compound comprising substituted piperidine structural unit
CN105339464A (en) * 2013-06-26 2016-02-17 捷恩智株式会社 Liquid crystal composition, and liquid crystal display element
US20150337202A1 (en) * 2014-05-26 2015-11-26 Jnc Corporation Liquid crystal composition and liquid crystal display device
US20160032188A1 (en) * 2014-07-29 2016-02-04 Jnc Corporation Liquid crystal composition and liquid crystal display device
CN106281357A (en) * 2015-05-21 2017-01-04 默克专利股份有限公司 Liquid crystal media and the liquid crystal display comprising it
CN107686462A (en) * 2016-08-05 2018-02-13 默克专利股份有限公司 Piperidine derivative and liquid crystal media

Also Published As

Publication number Publication date
WO2019228938A1 (en) 2019-12-05
EP3802731A1 (en) 2021-04-14
TWI845512B (en) 2024-06-21
TW202003809A (en) 2020-01-16
KR20210014685A (en) 2021-02-09

Similar Documents

Publication Publication Date Title
CN108373441B (en) Compounds and liquid-crystalline media
CN108373924B (en) Compounds and liquid-crystalline media
KR102245564B1 (en) Liquid-crystalline medium, method for the stabilisation thereof, and liquid-crystal display
TWI573789B (en) Compounds and liquid-crystalline medium
KR102245557B1 (en) Liquid-crystalline medium, method for the stabilisation thereof, and liquid-crystal display
KR20190085057A (en) Liquid crystal medium and liquid crystal display comprising same
CN112218933A (en) Compound and liquid-crystalline medium
CN112236499A (en) Compound and liquid-crystalline medium
CN107686462B (en) Piperidine derivatives and liquid-crystalline medium
TW202436597A (en) Compounds and liquid-crystalline medium

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination